{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:39:53Z","timestamp":1792687193683,"version":"4.5.0"},"reference-count":379,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"DOI":"10.1007\/s00432-026-06566-x","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T07:45:53Z","timestamp":1785138353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The pivotal role of macrophages in tumorigenesis and pioneering cancer immunotherapy across pre-clinical and clinical frontiers"],"prefix":"10.1007","volume":"152","author":[{"given":"Mina","family":"Alimohammadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Mohammad","family":"Mirnejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najma","family":"Farahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Hedayati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5682-5392","authenticated-orcid":false,"given":"Kiavash","family":"Hushmandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"6566_CR291","unstructured":"Sani, E., Design and implementation of a GMP production of a highly potent therapeutic antibody product in a new facility designed for single-use systems. 2025."},{"issue":"5","key":"6566_CR1","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41587-019-0064-8","volume":"37","author":"A Aalipour","year":"2019","unstructured":"Aalipour A et al (2019) Engineered immune cells as highly sensitive cancer diagnostics. Nat Biotechnol 37(5):531\u2013539","journal-title":"Nat Biotechnol"},{"issue":"1","key":"6566_CR2","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12967-020-02251-w","volume":"18","author":"MH Abdelaziz","year":"2020","unstructured":"Abdelaziz MH et al (2020) Alternatively activated macrophages; a double-edged sword in allergic asthma. J Transl Med 18(1):58","journal-title":"J Transl Med"},{"issue":"2","key":"6566_CR3","doi-asserted-by":"publisher","first-page":"625","DOI":"10.4049\/jimmunol.144.2.625","volume":"144","author":"SL Abramson","year":"1990","unstructured":"Abramson SL, Gallin JI (1990) IL-4 inhibits superoxide production by human mononuclear phagocytes. J Immunol 144(2):625\u2013630","journal-title":"J Immunol"},{"key":"6566_CR4","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaw7843","author":"L Akkari","year":"2020","unstructured":"Akkari L et al (2020) Dynamic changes in glioma macrophage populations after radiotherapy reveal CSF-1R inhibition as a strategy to overcome resistance. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aaw7843","journal-title":"Sci Transl Med"},{"key":"6566_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.phrs.2017.05.002","volume":"122","author":"SA Amin","year":"2017","unstructured":"Amin SA, Adhikari N, Jha T (2017) Is dual inhibition of metalloenzymes HDAC-8 and MMP-2 a potential pharmacological target to combat hematological malignancies? Pharmacol Res 122:8\u201319","journal-title":"Pharmacol Res"},{"issue":"2","key":"6566_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ccr.2009.12.019","volume":"17","author":"P Andreu","year":"2010","unstructured":"Andreu P et al (2010) Fcrgamma activation regulates inflammation-associated squamous carcinogenesis. Cancer Cell 17(2):121\u2013134","journal-title":"Cancer Cell"},{"issue":"2","key":"6566_CR7","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/cas.13467","volume":"109","author":"K Arima","year":"2018","unstructured":"Arima K et al (2018) Downregulation of 15-hydroxyprostaglandin dehydrogenase by interleukin-1\u03b2 from activated macrophages leads to poor prognosis in pancreatic cancer. Cancer Sci 109(2):462\u2013470","journal-title":"Cancer Sci"},{"issue":"389","key":"6566_CR8","doi-asserted-by":"publisher","first-page":"eaa13604","DOI":"10.1126\/scitranslmed.aal3604","volume":"9","author":"SP Arlauckas","year":"2017","unstructured":"Arlauckas SP et al (2017) In vivo imaging reveals a tumor-associated macrophage\u2013mediated resistance pathway in anti\u2013PD-1 therapy. Sci Transl Med 9(389):eaa13604","journal-title":"Sci Transl Med"},{"issue":"10","key":"6566_CR9","doi-asserted-by":"publisher","DOI":"10.4161\/21624011.2014.955709","volume":"3","author":"MS Arredouani","year":"2014","unstructured":"Arredouani MS (2014) Is the scavenger receptor MARCO a new immune checkpoint? Oncoimmunology 3(10):e955709","journal-title":"Oncoimmunology"},{"issue":"20","key":"6566_CR10","doi-asserted-by":"publisher","first-page":"6030","DOI":"10.1158\/0008-5472.CAN-16-1170","volume":"76","author":"M Baghdadi","year":"2016","unstructured":"Baghdadi M et al (2016) Chemotherapy-induced IL34 enhances immunosuppression by tumor-associated macrophages and mediates survival of chemoresistant lung cancer cells. Cancer Res 76(20):6030\u20136042","journal-title":"Cancer Res"},{"issue":"7","key":"6566_CR11","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1196299","volume":"5","author":"KS Baghel","year":"2016","unstructured":"Baghel KS et al (2016) Macrophages promote matrix protrusive and invasive function of breast cancer cells via MIP-1\u03b2 dependent upregulation of MYO3A gene in breast cancer cells. Oncoimmunology 5(7):e1196299","journal-title":"Oncoimmunology"},{"key":"6566_CR12","volume":"10","author":"SK Baidya","year":"2024","unstructured":"Baidya SK et al (2024) Matrix metalloproteinase-8 (MMP-8) and its inhibitors: a minireview. Eur J Med Chem Rep 10:100130","journal-title":"Eur J Med Chem Rep"},{"issue":"6","key":"6566_CR13","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1080\/17512433.2020.1771179","volume":"13","author":"GG Baldi","year":"2020","unstructured":"Baldi GG, Gronchi A, Stacchiotti S (2020) Pexidartinib for the treatment of adult symptomatic patients with tenosynovial giant cell tumors. Expert Rev Clin Pharmacol 13(6):571\u2013576","journal-title":"Expert Rev Clin Pharmacol"},{"key":"6566_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1146\/annurev-immunol-032713-120142","volume":"32","author":"AN Barclay","year":"2014","unstructured":"Barclay AN, Van den Berg TK (2014) The interaction between signal regulatory protein alpha (SIRP\u03b1) and CD47: structure, function, and therapeutic target. Annu Rev Immunol 32:25\u201350","journal-title":"Annu Rev Immunol"},{"issue":"6","key":"6566_CR15","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.ccr.2012.04.025","volume":"21","author":"LJ Bayne","year":"2012","unstructured":"Bayne LJ et al (2012) Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer Cell 21(6):822\u2013835","journal-title":"Cancer Cell"},{"issue":"6024","key":"6566_CR16","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1126\/science.1198443","volume":"331","author":"GL Beatty","year":"2011","unstructured":"Beatty GL et al (2011) CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. Science 331(6024):1612\u20131616","journal-title":"Science"},{"issue":"22","key":"6566_CR17","doi-asserted-by":"publisher","first-page":"6286","DOI":"10.1158\/1078-0432.CCR-13-1320","volume":"19","author":"GL Beatty","year":"2013","unstructured":"Beatty GL et al (2013) A phase I study of an agonist CD40 monoclonal antibody (CP-870,893) in combination with gemcitabine in patients with advanced pancreatic ductal adenocarcinoma. Clin Cancer Res 19(22):6286\u20136295","journal-title":"Clin Cancer Res"},{"issue":"6657","key":"6566_CR18","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1126\/science.ade2292","volume":"381","author":"R Bill","year":"2023","unstructured":"Bill R et al (2023) CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers. Science 381(6657):515\u2013524","journal-title":"Science"},{"issue":"10","key":"6566_CR19","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/ni.1937","volume":"11","author":"SK Biswas","year":"2010","unstructured":"Biswas SK, Mantovani A (2010) Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 11(10):889\u2013896","journal-title":"Nat Immunol"},{"issue":"1","key":"6566_CR20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/000509716","volume":"13","author":"T Bleul","year":"2021","unstructured":"Bleul T et al (2021) Different innate immune responses in BALB\/c and C57BL\/6 strains following corneal transplantation. J Innate Immun 13(1):49\u201359","journal-title":"J Innate Immun"},{"issue":"12","key":"6566_CR21","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1038\/s41590-018-0226-8","volume":"19","author":"T Bohn","year":"2018","unstructured":"Bohn T et al (2018) Tumor immunoevasion via acidosis-dependent induction of regulatory tumor-associated macrophages. Nat Immunol 19(12):1319\u20131329","journal-title":"Nat Immunol"},{"issue":"7525","key":"6566_CR22","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/nature13862","volume":"515","author":"L Bonapace","year":"2014","unstructured":"Bonapace L et al (2014) Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis. Nature 515(7525):130\u2013133","journal-title":"Nature"},{"key":"6566_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1471-2407-12-35","volume":"12","author":"AK Bonde","year":"2012","unstructured":"Bonde AK et al (2012) Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors. BMC Cancer 12:35","journal-title":"BMC Cancer"},{"key":"6566_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22136995","author":"AJ Boutilier","year":"2021","unstructured":"Boutilier AJ, Elsawa SF (2021) Macrophage polarization states in the tumor microenvironment. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22136995","journal-title":"Int J Mol Sci"},{"issue":"9","key":"6566_CR25","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1016\/j.celrep.2016.10.052","volume":"17","author":"RL Bowman","year":"2016","unstructured":"Bowman RL et al (2016) Macrophage ontogeny underlies differences in tumor-specific education in brain malignancies. Cell Rep 17(9):2445\u20132459","journal-title":"Cell Rep"},{"issue":"1","key":"6566_CR26","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11523-014-0320-2","volume":"10","author":"I Brana","year":"2015","unstructured":"Brana I et al (2015) Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study. Target Oncol 10(1):111\u2013123","journal-title":"Target Oncol"},{"issue":"5","key":"6566_CR27","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.ccell.2021.02.013","volume":"39","author":"DA Braun","year":"2021","unstructured":"Braun DA et al (2021) Progressive immune dysfunction with advancing disease stage in renal cell carcinoma. Cancer Cell 39(5):632-648.e8","journal-title":"Cancer Cell"},{"issue":"12","key":"6566_CR28","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1016\/j.celrep.2016.05.058","volume":"15","author":"KT Byrne","year":"2016","unstructured":"Byrne KT, Vonderheide RH (2016) CD40 stimulation obviates innate sensors and drives T cell immunity in cancer. Cell Rep 15(12):2719\u20132732","journal-title":"Cell Rep"},{"issue":"1","key":"6566_CR29","doi-asserted-by":"publisher","first-page":"252","DOI":"10.4143\/crt.2017.613","volume":"51","author":"J Cai","year":"2019","unstructured":"Cai J et al (2019) Tumor-associated macrophages derived TGF-\u03b2-induced epithelial to mesenchymal transition in colorectal cancer cells through Smad 2,3\u20134\/Snail signaling pathway. Cancer Res Treat 51(1):252\u2013266","journal-title":"Cancer Res Treat"},{"issue":"10","key":"6566_CR30","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1084\/jem.20150496","volume":"212","author":"B Calderon","year":"2015","unstructured":"Calderon B et al (2015) The pancreas anatomy conditions the origin and properties of resident macrophages. J Exp Med 212(10):1497\u20131512","journal-title":"J Exp Med"},{"key":"6566_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/v13061062","author":"V Callahan","year":"2021","unstructured":"Callahan V et al (2021) The pro-inflammatory chemokines CXCL9, CXCL10 and CXCL11 are upregulated following SARS-CoV-2 infection in an AKT-dependent manner. Viruses. https:\/\/doi.org\/10.3390\/v13061062","journal-title":"Viruses"},{"issue":"1","key":"6566_CR32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40425-017-0257-y","volume":"5","author":"MA Cannarile","year":"2017","unstructured":"Cannarile MA et al (2017) Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy. J Immunother Cancer 5(1):53","journal-title":"J Immunother Cancer"},{"issue":"8","key":"6566_CR33","doi-asserted-by":"publisher","first-page":"7738","DOI":"10.1021\/acsnano.6b03148","volume":"10","author":"H Cao","year":"2016","unstructured":"Cao H et al (2016) Liposomes coated with isolated macrophage membrane can target lung metastasis of breast cancer. ACS Nano 10(8):7738\u20137748","journal-title":"ACS Nano"},{"issue":"8","key":"6566_CR34","doi-asserted-by":"publisher","first-page":"4762","DOI":"10.1021\/acs.nanolett.8b01236","volume":"18","author":"H Cao","year":"2018","unstructured":"Cao H et al (2018) Bioengineered macrophages can responsively transform into nanovesicles to target lung metastasis. Nano Lett 18(8):4762\u20134770","journal-title":"Nano Lett"},{"key":"6566_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.01986","volume":"11","author":"FO Cardoso","year":"2020","unstructured":"Cardoso FO et al (2020) Modulation of cytokines and extracellular matrix proteins expression by Leishmania amazonensis in susceptible and resistant mice. Front Microbiol 11:1986","journal-title":"Front Microbiol"},{"issue":"6","key":"6566_CR36","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.ccr.2013.11.007","volume":"24","author":"A Casazza","year":"2013","unstructured":"Casazza A et al (2013) Impeding macrophage entry into hypoxic tumor areas by Sema3A\/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity. Cancer Cell 24(6):695\u2013709","journal-title":"Cancer Cell"},{"issue":"4","key":"6566_CR37","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.ccell.2019.02.009","volume":"35","author":"L Cassetta","year":"2019","unstructured":"Cassetta L et al (2019) Human tumor-associated macrophage and monocyte transcriptional landscapes reveal cancer-specific reprogramming, biomarkers, and therapeutic targets. Cancer Cell 35(4):588-602.e10","journal-title":"Cancer Cell"},{"issue":"7","key":"6566_CR38","first-page":"1578","volume":"55","author":"SK Chambers","year":"1995","unstructured":"Chambers SK et al (1995) Macrophage colony-stimulating factor mediates invasion of ovarian cancer cells through urokinase. Cancer Res 55(7):1578\u20131585","journal-title":"Cancer Res"},{"issue":"6","key":"6566_CR39","first-page":"999","volume":"3","author":"SK Chambers","year":"1997","unstructured":"Chambers SK et al (1997) Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1. Clin Cancer Res 3(6):999\u20131007","journal-title":"Clin Cancer Res"},{"issue":"10","key":"6566_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076024","volume":"8","author":"YN Chang","year":"2013","unstructured":"Chang YN et al (2013) Adjusting the balance between effective loading and vector migration of macrophage vehicles to deliver nanoparticles. PLoS ONE 8(10):e76024","journal-title":"PLoS ONE"},{"issue":"19","key":"6566_CR41","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.1158\/0008-5472.CAN-16-0144","volume":"76","author":"AL Chang","year":"2016","unstructured":"Chang AL et al (2016) CCL2 produced by the glioma microenvironment is essential for the recruitment of regulatory T cells and myeloid-derived suppressor cells. Cancer Res 76(19):5671\u20135682","journal-title":"Cancer Res"},{"issue":"1","key":"6566_CR42","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12865-021-00413-z","volume":"22","author":"WT Chang","year":"2021","unstructured":"Chang WT et al (2021) Mutant glucocorticoid receptor binding elements on the interleukin-6 promoter regulate dexamethasone effects. BMC Immunol 22(1):24","journal-title":"BMC Immunol"},{"issue":"3","key":"6566_CR43","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.3390\/cancers6031670","volume":"6","author":"T Chanmee","year":"2014","unstructured":"Chanmee T et al (2014) Tumor-associated macrophages as major players in the tumor microenvironment. Cancers 6(3):1670\u20131690","journal-title":"Cancers"},{"issue":"2","key":"6566_CR44","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s44222-022-00004-6","volume":"1","author":"Y Chao","year":"2023","unstructured":"Chao Y, Liu Z (2023) Biomaterials tools to modulate the tumour microenvironment in immunotherapy. Nat Rev Bioeng 1(2):125\u2013138","journal-title":"Nat Rev Bioeng"},{"issue":"2","key":"6566_CR45","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.cell.2011.09.022","volume":"147","author":"H Chen","year":"2011","unstructured":"Chen H et al (2011a) Activation of STAT6 by STING is critical for antiviral innate immunity. Cell 147(2):436\u2013446","journal-title":"Cell"},{"issue":"4","key":"6566_CR46","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.ccr.2011.02.006","volume":"19","author":"J Chen","year":"2011","unstructured":"Chen J et al (2011b) CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3. Cancer Cell 19(4):541\u2013555","journal-title":"Cancer Cell"},{"issue":"2","key":"6566_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.33","volume":"7","author":"W Chen","year":"2016","unstructured":"Chen W et al (2016) Attenuation of the programmed cell death-1 pathway increases the M1 polarization of macrophages induced by zymosan. Cell Death Dis 7(2):e2115","journal-title":"Cell Death Dis"},{"issue":"9","key":"6566_CR48","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1158\/0008-5472.CAN-16-2310","volume":"77","author":"Z Chen","year":"2017","unstructured":"Chen Z et al (2017) Cellular and molecular identity of tumor-associated macrophages in glioblastoma. Cancer Res 77(9):2266\u20132278","journal-title":"Cancer Res"},{"issue":"1","key":"6566_CR49","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","volume":"8","author":"S Chen","year":"2023","unstructured":"Chen S et al (2023) Macrophages in immunoregulation and therapeutics. Signal Transduct Target Ther 8(1):207","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"6566_CR50","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","volume":"184","author":"S Cheng","year":"2021","unstructured":"Cheng S et al (2021) A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell 184(3):792-809.e23","journal-title":"Cell"},{"issue":"9","key":"6566_CR51","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/ni.2376","volume":"13","author":"S Chiba","year":"2012","unstructured":"Chiba S et al (2012) Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1. Nat Immunol 13(9):832\u2013842","journal-title":"Nat Immunol"},{"issue":"1","key":"6566_CR52","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.coi.2005.11.006","volume":"18","author":"V Chitu","year":"2006","unstructured":"Chitu V, Stanley ER (2006) Colony-stimulating factor-1 in immunity and inflammation. Curr Opin Immunol 18(1):39\u201348","journal-title":"Curr Opin Immunol"},{"issue":"12","key":"6566_CR53","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1021\/nl072209h","volume":"7","author":"MR Choi","year":"2007","unstructured":"Choi MR et al (2007) A cellular Trojan horse for delivery of therapeutic nanoparticles into tumors. Nano Lett 7(12):3759\u20133765","journal-title":"Nano Lett"},{"issue":"16","key":"6566_CR54","doi-asserted-by":"publisher","first-page":"4195","DOI":"10.1016\/j.biomaterials.2012.02.022","volume":"33","author":"J Choi","year":"2012","unstructured":"Choi J et al (2012) Use of macrophages to deliver therapeutic and imaging contrast agents to tumors. Biomaterials 33(16):4195\u20134203","journal-title":"Biomaterials"},{"issue":"7","key":"6566_CR55","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.ccell.2021.05.006","volume":"39","author":"A Chow","year":"2021","unstructured":"Chow A et al (2021) Tim-4(+) cavity-resident macrophages impair anti-tumor CD8(+) T cell immunity. Cancer Cell 39(7):973-988.e9","journal-title":"Cancer Cell"},{"issue":"8","key":"6566_CR56","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1038\/s41590-022-01267-2","volume":"23","author":"A Christofides","year":"2022","unstructured":"Christofides A et al (2022) The complex role of tumor-infiltrating macrophages. Nat Immunol 23(8):1148\u20131156","journal-title":"Nat Immunol"},{"issue":"3","key":"6566_CR57","doi-asserted-by":"publisher","first-page":"E227","DOI":"10.1002\/ijc.27403","volume":"131","author":"FT Chung","year":"2012","unstructured":"Chung FT et al (2012) Tumor-associated macrophages correlate with response to epidermal growth factor receptor-tyrosine kinase inhibitors in advanced non-small cell lung cancer. Int J Cancer 131(3):E227\u2013E235","journal-title":"Int J Cancer"},{"issue":"7519","key":"6566_CR58","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature13490","volume":"513","author":"OR Colegio","year":"2014","unstructured":"Colegio OR et al (2014) Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 513(7519):559\u2013563","journal-title":"Nature"},{"key":"6566_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-36667-4_1","volume":"1231","author":"MJ Conroy","year":"2020","unstructured":"Conroy MJ, Lysaght J (2020) CX3CL1 signaling in the tumor microenvironment. Adv Exp Med Biol 1231:1\u201312","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"6566_CR60","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1039\/b808331m","volume":"26","author":"C Cuevas","year":"2009","unstructured":"Cuevas C, Francesch A (2009) Development of Yondelis (trabectedin, ET-743). A semisynthetic process solves the supply problem. Nat Prod Rep 26(3):322\u2013337","journal-title":"Nat Prod Rep"},{"issue":"8","key":"6566_CR71","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1158\/1535-7163.MCT-10-0263","volume":"9","author":"M D'Incalci","year":"2010","unstructured":"D\u2019Incalci M, Galmarini CM (2010) A review of trabectedin (ET-743): a unique mechanism of action. Mol Cancer Ther 9(8):2157\u20132163","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"6566_CR72","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/bjc.2014.149","volume":"111","author":"M D'Incalci","year":"2014","unstructured":"D\u2019Incalci M et al (2014) Trabectedin, a drug acting on both cancer cells and the tumour microenvironment. Br J Cancer 111(4):646\u2013650","journal-title":"Br J Cancer"},{"issue":"7","key":"6566_CR61","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1093\/jnci\/djv439","volume":"108","author":"H Dai","year":"2016","unstructured":"Dai H et al (2016) Chimeric antigen receptors modified T-cells for cancer therapy. J Natl Cancer Inst 108(7):439","journal-title":"J Natl Cancer Inst"},{"issue":"19","key":"6566_CR62","doi-asserted-by":"publisher","first-page":"9341","DOI":"10.1039\/C8NR03364A","volume":"11","author":"B Dalzon","year":"2019","unstructured":"Dalzon B et al (2019) Utility of macrophages in an antitumor strategy based on the vectorization of iron oxide nanoparticles. Nanoscale 11(19):9341\u20139352","journal-title":"Nanoscale"},{"issue":"4","key":"6566_CR63","first-page":"429","volume":"17","author":"G De Cunto","year":"2020","unstructured":"De Cunto G et al (2020) Alveolar macrophage phenotype and compartmentalization drive different pulmonary changes in mouse strains exposed to cigarette smoke. COPD J Chronic Obstr Pulm Dis 17(4):429\u2013443","journal-title":"COPD J Chronic Obstr Pulm Dis"},{"issue":"4","key":"6566_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/toxics5040029","volume":"5","author":"V De Matteis","year":"2017","unstructured":"De Matteis V (2017) Exposure to inorganic nanoparticles: routes of entry, immune response, biodistribution and in vitro\/in vivo toxicity evaluation. Toxics 5(4):29","journal-title":"Toxics"},{"issue":"8","key":"6566_CR65","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1200\/JCO.2015.62.4734","volume":"34","author":"GD Demetri","year":"2016","unstructured":"Demetri GD et al (2016) Efficacy and safety of trabectedin or dacarbazine for metastatic liposarcoma or leiomyosarcoma after failure of conventional chemotherapy: results of a phase III randomized multicenter clinical trial. J Clin Oncol 34(8):786\u2013793","journal-title":"J Clin Oncol"},{"issue":"6","key":"6566_CR66","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","volume":"19","author":"DG DeNardo","year":"2019","unstructured":"DeNardo DG, Ruffell B (2019) Macrophages as regulators of tumour immunity and immunotherapy. Nat Rev Immunol 19(6):369\u2013382","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"6566_CR67","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1158\/2159-8274.CD-10-0028","volume":"1","author":"DG DeNardo","year":"2011","unstructured":"DeNardo DG et al (2011) Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discov 1(1):54\u201367","journal-title":"Cancer Discov"},{"issue":"24","key":"6566_CR68","doi-asserted-by":"publisher","first-page":"6668","DOI":"10.1158\/1078-0432.CCR-12-0984","volume":"18","author":"MZ Dewan","year":"2012","unstructured":"Dewan MZ et al (2012) Synergy of topical toll-like receptor 7 agonist with radiation and low-dose cyclophosphamide in a mouse model of cutaneous breast cancer. Clin Cancer Res 18(24):6668\u20136678","journal-title":"Clin Cancer Res"},{"issue":"10","key":"6566_CR69","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41568-018-0037-0","volume":"18","author":"F Di Virgilio","year":"2018","unstructured":"Di Virgilio F et al (2018) Extracellular ATP and P2 purinergic signalling in the tumour microenvironment. Nat Rev Cancer 18(10):601\u2013618","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"6566_CR70","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1056\/NEJM199808063390601","volume":"339","author":"IJ Diel","year":"1998","unstructured":"Diel IJ et al (1998) Reduction in new metastases in breast cancer with adjuvant clodronate treatment. N Engl J Med 339(6):357\u2013363","journal-title":"N Engl J Med"},{"issue":"11","key":"6566_CR73","doi-asserted-by":"publisher","first-page":"4340","DOI":"10.1158\/0008-5472.CAN-07-6705","volume":"68","author":"SP Dineen","year":"2008","unstructured":"Dineen SP et al (2008) Vascular endothelial growth factor receptor 2 mediates macrophage infiltration into orthotopic pancreatic tumors in mice. Cancer Res 68(11):4340\u20134346","journal-title":"Cancer Res"},{"issue":"7865","key":"6566_CR74","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41586-021-03626-9","volume":"595","author":"KO Dixon","year":"2021","unstructured":"Dixon KO et al (2021) TIM-3 restrains anti-tumour immunity by regulating inflammasome activation. Nature 595(7865):101\u2013106","journal-title":"Nature"},{"issue":"19","key":"6566_CR75","doi-asserted-by":"publisher","first-page":"7465","DOI":"10.1158\/0008-5472.CAN-10-1439","volume":"70","author":"AL Doedens","year":"2010","unstructured":"Doedens AL et al (2010) Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression. Cancer Res 70(19):7465\u20137475","journal-title":"Cancer Res"},{"key":"6566_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.117154","volume":"283","author":"JS Dorjay Tamang","year":"2025","unstructured":"Dorjay Tamang JS et al (2025) An overview of matrix metalloproteinase-12 in multiple disease conditions, potential selective inhibitors, and drug designing strategies. Eur J Med Chem 283:117154","journal-title":"Eur J Med Chem"},{"issue":"12","key":"6566_CR77","doi-asserted-by":"publisher","first-page":"H105","DOI":"10.1002\/adma.201004074","volume":"23","author":"N Doshi","year":"2011","unstructured":"Doshi N et al (2011) Cell-based drug delivery devices using phagocytosis-resistant backpacks. Adv Mater 23(12):H105\u2013H109","journal-title":"Adv Mater"},{"issue":"7676","key":"6566_CR78","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/nature24050","volume":"550","author":"Z Dou","year":"2017","unstructured":"Dou Z et al (2017) Cytoplasmic chromatin triggers inflammation in senescence and cancer. Nature 550(7676):402\u2013406","journal-title":"Nature"},{"issue":"1","key":"6566_CR79","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41392-021-00506-6","volume":"6","author":"Z Duan","year":"2021","unstructured":"Duan Z, Luo Y (2021) Targeting macrophages in cancer immunotherapy. Signal Transduct Target Ther 6(1):127","journal-title":"Signal Transduct Target Ther"},{"issue":"26","key":"6566_CR80","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1056\/NEJM198612253152606","volume":"315","author":"HF Dvorak","year":"1986","unstructured":"Dvorak HF (1986) Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315(26):1650\u20131659","journal-title":"N Engl J Med"},{"issue":"4","key":"6566_CR81","first-page":"342","volume":"20","author":"R Ebert","year":"1939","unstructured":"Ebert R, Florey H (1939) The extravascular development of the monocyte observed in vivo. Br J Exp Pathol 20(4):342","journal-title":"Br J Exp Pathol"},{"issue":"10","key":"6566_CR82","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047045","volume":"7","author":"S Edin","year":"2012","unstructured":"Edin S et al (2012) The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer. PLoS ONE 7(10):e47045","journal-title":"PLoS ONE"},{"issue":"7","key":"6566_CR84","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41416-019-0542-2","volume":"121","author":"A El-Kenawi","year":"2019","unstructured":"El-Kenawi A et al (2019) Acidity promotes tumour progression by altering macrophage phenotype in prostate cancer. Br J Cancer 121(7):556\u2013566","journal-title":"Br J Cancer"},{"issue":"1","key":"6566_CR83","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1600-065X.2009.00782.x","volume":"229","author":"R Elgueta","year":"2009","unstructured":"Elgueta R et al (2009) Molecular mechanism and function of CD40\/CD40L engagement in the immune system. Immunol Rev 229(1):152\u2013172","journal-title":"Immunol Rev"},{"issue":"7","key":"6566_CR85","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nrc.2016.54","volume":"16","author":"C Engblom","year":"2016","unstructured":"Engblom C, Pfirschke C, Pittet MJ (2016) The role of myeloid cells in cancer therapies. Nat Rev Cancer 16(7):447\u2013462","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"6566_CR86","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.canlet.2014.05.008","volume":"352","author":"QM Fan","year":"2014","unstructured":"Fan QM et al (2014) Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma. Cancer Lett 352(2):160\u2013168","journal-title":"Cancer Lett"},{"issue":"7","key":"6566_CR87","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1016\/j.ultrasmedbio.2018.03.009","volume":"44","author":"CH Fan","year":"2018","unstructured":"Fan CH et al (2018) Macrophages as drug delivery carriers for acoustic phase-change droplets. Ultrasound Med Biol 44(7):1468\u20131481","journal-title":"Ultrasound Med Biol"},{"issue":"23","key":"6566_CR88","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201706759","volume":"30","author":"RH Fang","year":"2018","unstructured":"Fang RH et al (2018) Cell membrane coating nanotechnology. Adv Mater 30(23):e1706759","journal-title":"Adv Mater"},{"issue":"2","key":"6566_CR89","first-page":"151","volume":"948","author":"IJ Fidler","year":"1988","unstructured":"Fidler IJ, Schroit AJ (1988) Recognition and destruction of neoplastic cells by activated macrophages: discrimination of altered self. Biochim Biophys Acta 948(2):151\u2013173","journal-title":"Biochim Biophys Acta"},{"issue":"6186","key":"6566_CR90","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.1252510","volume":"344","author":"RA Franklin","year":"2014","unstructured":"Franklin RA et al (2014) The cellular and molecular origin of tumor-associated macrophages. Science 344(6186):921\u2013925","journal-title":"Science"},{"issue":"11","key":"6566_CR91","doi-asserted-by":"publisher","first-page":"7884","DOI":"10.1074\/jbc.M113.522037","volume":"289","author":"AJ Freemerman","year":"2014","unstructured":"Freemerman AJ et al (2014) Metabolic reprogramming of macrophages: glucose transporter 1 (GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype. J Biol Chem 289(11):7884\u20137896","journal-title":"J Biol Chem"},{"issue":"1","key":"6566_CR92","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1158\/0008-5472.CAN-09-2326","volume":"70","author":"ZG Fridlender","year":"2010","unstructured":"Fridlender ZG et al (2010) CCL2 blockade augments cancer immunotherapy. Cancer Res 70(1):109\u2013118","journal-title":"Cancer Res"},{"key":"6566_CR93","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jconrel.2015.01.039","volume":"204","author":"J Fu","year":"2015","unstructured":"Fu J et al (2015) Macrophage mediated biomimetic delivery system for the treatment of lung metastasis of breast cancer. J Control Release 204:11\u201319","journal-title":"J Control Release"},{"issue":"11","key":"6566_CR94","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/ni.2419","volume":"13","author":"EL Gautier","year":"2012","unstructured":"Gautier EL et al (2012) Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat Immunol 13(11):1118\u20131128","journal-title":"Nat Immunol"},{"key":"6566_CR95","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3389\/fimmu.2017.00289","volume":"8","author":"X Geeraerts","year":"2017","unstructured":"Geeraerts X et al (2017) Macrophage metabolism as therapeutic target for cancer, atherosclerosis, and obesity. Front Immunol 8:289","journal-title":"Front Immunol"},{"issue":"8","key":"6566_CR96","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/nm.3909","volume":"21","author":"AJ Gentles","year":"2015","unstructured":"Gentles AJ et al (2015) The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat Med 21(8):938\u2013945","journal-title":"Nat Med"},{"issue":"9","key":"6566_CR97","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1016\/j.celrep.2016.04.084","volume":"15","author":"AM Georgoudaki","year":"2016","unstructured":"Georgoudaki AM et al (2016) Reprogramming tumor-associated macrophages by antibody targeting inhibits cancer progression and metastasis. Cell Rep 15(9):2000\u20132011","journal-title":"Cell Rep"},{"issue":"6","key":"6566_CR98","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1158\/0008-5472.CAN-09-2335","volume":"70","author":"G Germano","year":"2010","unstructured":"Germano G et al (2010) Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells. Cancer Res 70(6):2235\u20132244","journal-title":"Cancer Res"},{"issue":"2","key":"6566_CR99","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ccr.2013.01.008","volume":"23","author":"G Germano","year":"2013","unstructured":"Germano G et al (2013) Role of macrophage targeting in the antitumor activity of trabectedin. Cancer Cell 23(2):249\u2013262","journal-title":"Cancer Cell"},{"issue":"3","key":"6566_CR100","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.immuni.2016.02.024","volume":"44","author":"F Ginhoux","year":"2016","unstructured":"Ginhoux F, Guilliams M (2016) Tissue-resident macrophage ontogeny and homeostasis. Immunity 44(3):439\u2013449","journal-title":"Immunity"},{"issue":"6005","key":"6566_CR101","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1194637","volume":"330","author":"F Ginhoux","year":"2010","unstructured":"Ginhoux F et al (2010) Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330(6005):841\u2013845","journal-title":"Science"},{"issue":"5","key":"6566_CR102","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1172\/JCI200422087","volume":"114","author":"E Giraudo","year":"2004","unstructured":"Giraudo E, Inoue M, Hanahan D (2004) An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. J Clin Invest 114(5):623\u2013633","journal-title":"J Clin Invest"},{"issue":"12","key":"6566_CR103","doi-asserted-by":"publisher","first-page":"E2801","DOI":"10.1073\/pnas.1707929115","volume":"115","author":"E Giurisato","year":"2018","unstructured":"Giurisato E et al (2018) Myeloid ERK5 deficiency suppresses tumor growth by blocking protumor macrophage polarization via STAT3 inhibition. Proc Natl Acad Sci U S A 115(12):E2801-e2810","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"6566_CR104","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.1158\/0008-5472.CAN-19-2416","volume":"80","author":"E Giurisato","year":"2020","unstructured":"Giurisato E et al (2020) Extracellular-regulated protein kinase 5-mediated control of p21 expression promotes macrophage proliferation associated with tumor growth and metastasis. Cancer Res 80(16):3319\u20133330","journal-title":"Cancer Res"},{"key":"6566_CR105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphys.2012.00001","volume":"3","author":"CA Gleissner","year":"2012","unstructured":"Gleissner CA (2012) Macrophage phenotype modulation by CXCL4 in atherosclerosis. Front Physiol 3:1","journal-title":"Front Physiol"},{"issue":"6371","key":"6566_CR106","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","volume":"359","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan V et al (2018) Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359(6371):97\u2013103","journal-title":"Science"},{"issue":"Suppl 1","key":"6566_CR107","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1002\/eji.200737638","volume":"37","author":"S Gordon","year":"2007","unstructured":"Gordon S (2007) The macrophage: past, present and future. Eur J Immunol 37(Suppl 1):S9-17","journal-title":"Eur J Immunol"},{"issue":"1","key":"6566_CR108","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/imr.12223","volume":"262","author":"S Gordon","year":"2014","unstructured":"Gordon S, Pl\u00fcddemann A, Martinez Estrada F (2014) Macrophage heterogeneity in tissues: phenotypic diversity and functions. Immunol Rev 262(1):36\u201355","journal-title":"Immunol Rev"},{"issue":"7655","key":"6566_CR109","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature22396","volume":"545","author":"SR Gordon","year":"2017","unstructured":"Gordon SR et al (2017) PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. Nature 545(7655):495\u2013499","journal-title":"Nature"},{"issue":"6","key":"6566_CR110","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.cell.2014.11.023","volume":"159","author":"D Gosselin","year":"2014","unstructured":"Gosselin D et al (2014) Environment drives selection and function of enhancers controlling tissue-specific macrophage identities. Cell 159(6):1327\u20131340","journal-title":"Cell"},{"issue":"5","key":"6566_CR111","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1365-3083.2008.02091.x","volume":"67","author":"E Gottfried","year":"2008","unstructured":"Gottfried E et al (2008) Expression of CD68 in non-myeloid cell types. Scand J Immunol 67(5):453\u2013463","journal-title":"Scand J Immunol"},{"issue":"5","key":"6566_CR112","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1002\/eji.201747283","volume":"48","author":"AM Grabiec","year":"2018","unstructured":"Grabiec AM et al (2018) Axl and MerTK receptor tyrosine kinases maintain human macrophage efferocytic capacity in the presence of viral triggers. Eur J Immunol 48(5):855\u2013860","journal-title":"Eur J Immunol"},{"issue":"2","key":"6566_CR116","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1172\/JCI66776","volume":"124","author":"N G\u00fcl","year":"2014","unstructured":"G\u00fcl N et al (2014) Macrophages eliminate circulating tumor cells after monoclonal antibody therapy. J Clin Invest 124(2):812\u2013823","journal-title":"J Clin Invest"},{"issue":"5","key":"6566_CR113","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.molmed.2018.03.006","volume":"24","author":"JL Guerriero","year":"2018","unstructured":"Guerriero JL (2018) Macrophages: the road less traveled, changing anticancer therapy. Trends Mol Med 24(5):472\u2013489","journal-title":"Trends Mol Med"},{"issue":"6","key":"6566_CR114","doi-asserted-by":"publisher","first-page":"3517","DOI":"10.4049\/jimmunol.1003267","volume":"186","author":"JL Guerriero","year":"2011","unstructured":"Guerriero JL et al (2011) DNA alkylating therapy induces tumor regression through an HMGB1-mediated activation of innate immunity. J Immunol 186(6):3517\u20133526","journal-title":"J Immunol"},{"issue":"7645","key":"6566_CR115","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/nature21409","volume":"543","author":"JL Guerriero","year":"2017","unstructured":"Guerriero JL et al (2017) Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages. Nature 543(7645):428\u2013432","journal-title":"Nature"},{"issue":"23","key":"6566_CR118","doi-asserted-by":"publisher","first-page":"6936","DOI":"10.7150\/thno.37380","volume":"9","author":"L Guo","year":"2019","unstructured":"Guo L et al (2019b) Lipopolysaccharide-anchored macrophages hijack tumor microtube networks for selective drug transport and augmentation of antitumor effects in orthotopic lung cancer. Theranostics 9(23):6936\u20136948","journal-title":"Theranostics"},{"issue":"2","key":"6566_CR117","first-page":"1078","volume":"13","author":"L Guo","year":"2019","unstructured":"Guo L et al (2019a) Tunneling nanotubular expressways for ultrafast and accurate M1 macrophage delivery of anticancer drugs to metastatic ovarian carcinoma. ACS Nano 13(2):1078\u20131096","journal-title":"ACS Nano"},{"issue":"1","key":"6566_CR119","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-70967-2","volume":"10","author":"OL Gurvich","year":"2020","unstructured":"Gurvich OL et al (2020) Transcriptomics uncovers substantial variability associated with alterations in manufacturing processes of macrophage cell therapy products. Sci Rep 10(1):14049","journal-title":"Sci Rep"},{"issue":"9","key":"6566_CR120","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/0046-8177(94)90005-1","volume":"25","author":"A Hameed","year":"1994","unstructured":"Hameed A et al (1994) Immunohistochemical expression of CD68 antigen in human peripheral blood T cells. Hum Pathol 25(9):872\u2013876","journal-title":"Hum Pathol"},{"issue":"2","key":"6566_CR121","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1021\/acsnano.7b09107","volume":"12","author":"J Han","year":"2018","unstructured":"Han J et al (2018) Dual roles of graphene oxide to attenuate inflammation and elicit timely polarization of macrophage phenotypes for cardiac repair. ACS Nano 12(2):1959\u20131977","journal-title":"ACS Nano"},{"issue":"1","key":"6566_CR122","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/art.41072","volume":"72","author":"S Han","year":"2020","unstructured":"Han S et al (2020) Differential responsiveness of monocyte and macrophage subsets to interferon. Arthritis Rheumatol 72(1):100\u2013113","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"6566_CR123","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","volume":"21","author":"D Hanahan","year":"2012","unstructured":"Hanahan D, Coussens LM (2012) Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 21(3):309\u2013322","journal-title":"Cancer Cell"},{"issue":"5","key":"6566_CR124","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646\u2013674","journal-title":"Cell"},{"issue":"10","key":"6566_CR125","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1158\/2326-6066.CIR-17-0537","volume":"6","author":"GP Hartley","year":"2018","unstructured":"Hartley GP et al (2018) Programmed cell death ligand 1 (PD-L1) signaling regulates macrophage proliferation and activation. Cancer Immunol Res 6(10):1260\u20131273","journal-title":"Cancer Immunol Res"},{"issue":"3","key":"6566_CR126","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41568-019-0116-x","volume":"19","author":"JJ Havel","year":"2019","unstructured":"Havel JJ, Chowell D, Chan TA (2019) The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy. Nat Rev Cancer 19(3):133\u2013150","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"6566_CR127","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1177\/0192623320918241","volume":"49","author":"R Haworth","year":"2021","unstructured":"Haworth R, Sharpe M (2021) Accept or reject: the role of immune tolerance in the development of stem cell therapies and possible future approaches. Toxicol Pathol 49(7):1308\u20131316","journal-title":"Toxicol Pathol"},{"key":"6566_CR128","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.741305","volume":"12","author":"Z He","year":"2021","unstructured":"He Z, Zhang S (2021) Tumor-associated macrophages and their functional transformation in the hypoxic tumor microenvironment. Front Immunol 12:741305","journal-title":"Front Immunol"},{"issue":"9","key":"6566_CR129","doi-asserted-by":"publisher","first-page":"5546","DOI":"10.1021\/acs.nanolett.7b02330","volume":"17","author":"X He","year":"2017","unstructured":"He X et al (2017) Inflammatory monocytes loading protease-sensitive nanoparticles enable lung metastasis targeting and intelligent drug release for anti-metastasis therapy. Nano Lett 17(9):5546\u20135554","journal-title":"Nano Lett"},{"issue":"10","key":"6566_CR130","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.1172\/JCI84427","volume":"126","author":"AT Henze","year":"2016","unstructured":"Henze AT, Mazzone M (2016) The impact of hypoxia on tumor-associated macrophages. J Clin Invest 126(10):3672\u20133679","journal-title":"J Clin Invest"},{"issue":"16","key":"6566_CR131","doi-asserted-by":"publisher","first-page":"8155","DOI":"10.1158\/0008-5472.CAN-06-0179","volume":"66","author":"AB Herrero","year":"2006","unstructured":"Herrero AB et al (2006) Cross-talk between nucleotide excision and homologous recombination DNA repair pathways in the mechanism of action of antitumor trabectedin. Cancer Res 66(16):8155\u20138162","journal-title":"Cancer Res"},{"issue":"2","key":"6566_CR132","doi-asserted-by":"publisher","first-page":"550","DOI":"10.4049\/jimmunol.138.2.550","volume":"138","author":"JB Hibbs Jr.","year":"1987","unstructured":"Hibbs JB Jr., Vavrin Z, Taintor RR (1987) L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J Immunol 138(2):550\u2013565","journal-title":"J Immunol"},{"issue":"12","key":"6566_CR133","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1097\/JTO.0b013e3182745968","volume":"7","author":"S Hirayama","year":"2012","unstructured":"Hirayama S et al (2012) Prognostic impact of CD204-positive macrophages in lung squamous cell carcinoma: possible contribution of Cd204-positive macrophages to the tumor-promoting microenvironment. J Thorac Oncol 7(12):1790\u20131797","journal-title":"J Thorac Oncol"},{"issue":"4","key":"6566_CR134","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.immuni.2015.03.011","volume":"42","author":"G Hoeffel","year":"2015","unstructured":"Hoeffel G et al (2015) C-Myb(+) erythro-myeloid progenitor-derived fetal monocytes give rise to adult tissue-resident macrophages. Immunity 42(4):665\u2013678","journal-title":"Immunity"},{"key":"6566_CR135","first-page":"25","volume":"5","author":"CA Holden","year":"2010","unstructured":"Holden CA et al (2010) Surface engineering of macrophages with nanoparticles to generate a cell-nanoparticle hybrid vehicle for hypoxia-targeted drug delivery. Int J Nanomedicine 5:25\u201336","journal-title":"Int J Nanomedicine"},{"key":"6566_CR136","doi-asserted-by":"publisher","DOI":"10.3390\/biology11020246","author":"W Hu","year":"2022","unstructured":"Hu W, Spaink HP (2022) The role of TLR2 in infectious diseases caused by mycobacteria: from cell biology to therapeutic target. Biology. https:\/\/doi.org\/10.3390\/biology11020246","journal-title":"Biology"},{"issue":"1","key":"6566_CR137","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","volume":"6","author":"X Hu","year":"2021","unstructured":"Hu X et al (2021) The JAK\/STAT signaling pathway: from bench to clinic. Signal Transduct Target Ther 6(1):402","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"6566_CR138","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13046-024-02989-x","volume":"43","author":"Z Hu","year":"2024","unstructured":"Hu Z et al (2024) IL6-STAT3-C\/EBP\u03b2-IL6 positive feedback loop in tumor-associated macrophages promotes the EMT and metastasis of lung adenocarcinoma. J Exp Clin Cancer Res 43(1):63","journal-title":"J Exp Clin Cancer Res"},{"issue":"15","key":"6566_CR139","doi-asserted-by":"publisher","first-page":"6303","DOI":"10.1073\/pnas.0809422106","volume":"106","author":"X Huang","year":"2009","unstructured":"Huang X et al (2009) PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis. Proc Natl Acad Sci U S A 106(15):6303\u20136308","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6566_CR140","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/978-1-4939-7837-3_12","volume":"1784","author":"X Huang","year":"2018","unstructured":"Huang X et al (2018a) Polarizing macrophages in vitro. Methods Mol Biol 1784:119\u2013126","journal-title":"Methods Mol Biol"},{"issue":"5\u20136","key":"6566_CR141","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1080\/1061186X.2017.1419359","volume":"26","author":"Z Huang","year":"2018","unstructured":"Huang Z et al (2018b) Macrophages as an active tumour-targeting carrier of SN38-nanoparticles for cancer therapy. J Drug Target 26(5\u20136):458\u2013465","journal-title":"J Drug Target"},{"key":"6566_CR142","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.686155","volume":"12","author":"J Huang","year":"2021","unstructured":"Huang J et al (2021) Promising therapeutic targets for treatment of rheumatoid arthritis. Front Immunol 12:686155","journal-title":"Front Immunol"},{"issue":"4","key":"6566_CR143","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41590-019-0323-3","volume":"20","author":"P Hubel","year":"2019","unstructured":"Hubel P et al (2019) A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape. Nat Immunol 20(4):493\u2013502","journal-title":"Nat Immunol"},{"issue":"17","key":"6566_CR144","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1158\/0008-5472.CAN-14-3587","volume":"75","author":"R Hughes","year":"2015","unstructured":"Hughes R et al (2015) Perivascular M2 macrophages stimulate tumor relapse after chemotherapy. Cancer Res 75(17):3479\u20133491","journal-title":"Cancer Res"},{"issue":"6","key":"6566_CR145","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/bfgp\/elt028","volume":"12","author":"AP Hutchins","year":"2013","unstructured":"Hutchins AP, Diez D, Miranda-Saavedra D (2013) The IL-10\/STAT3-mediated anti-inflammatory response: recent developments and future challenges. Brief Funct Genomics 12(6):489\u2013498","journal-title":"Brief Funct Genomics"},{"issue":"17","key":"6566_CR146","doi-asserted-by":"publisher","first-page":"8740","DOI":"10.1158\/0008-5472.CAN-06-0470","volume":"66","author":"Y Ikehara","year":"2006","unstructured":"Ikehara Y et al (2006) A carbohydrate recognition-based drug delivery and controlled release system using intraperitoneal macrophages as a cellular vehicle. Cancer Res 66(17):8740\u20138748","journal-title":"Cancer Res"},{"issue":"8","key":"6566_CR147","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1172\/JCI39506","volume":"120","author":"HZ Imtiyaz","year":"2010","unstructured":"Imtiyaz HZ et al (2010) Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation. J Clin Invest 120(8):2699\u20132714","journal-title":"J Clin Invest"},{"key":"6566_CR149","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3389\/fmed.2018.00150","volume":"5","author":"RK Iyer","year":"2018","unstructured":"Iyer RK et al (2018) Industrializing autologous adoptive immunotherapies: manufacturing advances and challenges. Front Med 5:150","journal-title":"Front Med"},{"key":"6566_CR150","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12020297","author":"N Javaid","year":"2020","unstructured":"Javaid N, Choi S (2020) Toll-like receptors from the perspective of cancer treatment. Cancers. https:\/\/doi.org\/10.3390\/cancers12020297","journal-title":"Cancers"},{"key":"6566_CR151","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21072357","author":"Y Jia","year":"2020","unstructured":"Jia Y, Wei Y (2020) Modulators of microRNA function in the immune system. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21072357","journal-title":"Int J Mol Sci"},{"issue":"30","key":"6566_CR152","doi-asserted-by":"publisher","first-page":"12425","DOI":"10.1073\/pnas.1106645108","volume":"108","author":"M Jinushi","year":"2011","unstructured":"Jinushi M et al (2011) Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem\/initiating cells. Proc Natl Acad Sci U S A 108(30):12425\u201312430","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7779","key":"6566_CR153","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41586-019-1674-5","volume":"574","author":"RJ Johnston","year":"2019","unstructured":"Johnston RJ et al (2019) VISTA is an acidic pH-selective ligand for PSGL-1. Nature 574(7779):565\u2013570","journal-title":"Nature"},{"issue":"5","key":"6566_CR154","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/cpt.418","volume":"100","author":"RS Jones","year":"2016","unstructured":"Jones RS, Morris ME (2016) Monocarboxylate transporters: therapeutic targets and prognostic factors in disease. Clin Pharmacol Ther 100(5):454\u2013463","journal-title":"Clin Pharmacol Ther"},{"issue":"6382","key":"6566_CR155","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1126\/science.aar6711","volume":"359","author":"CH June","year":"2018","unstructured":"June CH et al (2018) CAR T cell immunotherapy for human cancer. Science 359(6382):1361\u20131365","journal-title":"Science"},{"key":"6566_CR156","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3389\/fncel.2020.00198","volume":"14","author":"AM Jurga","year":"2020","unstructured":"Jurga AM, Paleczna M, Kuter KZ (2020) Overview of general and discriminating markers of differential microglia phenotypes. Front Cell Neurosci 14:198","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"6566_CR157","first-page":"941","volume":"6","author":"BM Kacinski","year":"1991","unstructured":"Kacinski BM et al (1991) FMS (CSF-1 receptor) and CSF-1 transcripts and protein are expressed by human breast carcinomas in vivo and in vitro. Oncogene 6(6):941\u2013952","journal-title":"Oncogene"},{"key":"6566_CR158","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2025.102636","author":"N Kalter","year":"2025","unstructured":"Kalter N et al (2025) Off-target effects in CRISPR-Cas genome editing for human therapeutics: progress and challenges. Mol Ther Nucleic Acids. https:\/\/doi.org\/10.1016\/j.omtn.2025.102636","journal-title":"Mol Ther Nucleic Acids"},{"issue":"8","key":"6566_CR160","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1158\/2159-8290.CD-15-1346","volume":"6","author":"MM Kaneda","year":"2016","unstructured":"Kaneda MM et al (2016b) Macrophage PI3K\u03b3 drives pancreatic ductal adenocarcinoma progression. Cancer Discov 6(8):870\u2013885","journal-title":"Cancer Discov"},{"issue":"7629","key":"6566_CR159","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nature19834","volume":"539","author":"MM Kaneda","year":"2016","unstructured":"Kaneda MM et al (2016a) PI3K\u03b3 is a molecular switch that controls immune suppression. Nature 539(7629):437\u2013442","journal-title":"Nature"},{"issue":"11","key":"6566_CR161","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3390\/jfb15110324","volume":"15","author":"B Kaupbayeva","year":"2024","unstructured":"Kaupbayeva B et al (2024) Unlocking genome editing: advances and obstacles in CRISPR\/Cas delivery technologies. J Funct Biomater 15(11):324","journal-title":"J Funct Biomater"},{"key":"6566_CR162","doi-asserted-by":"publisher","first-page":"71","DOI":"10.12703\/r\/10-71","volume":"10","author":"AD Keegan","year":"2021","unstructured":"Keegan AD, Leonard WJ, Zhu J (2021) Recent advances in understanding the role of IL-4 signaling. Fac Rev 10:71","journal-title":"Fac Rev"},{"key":"6566_CR163","doi-asserted-by":"publisher","DOI":"10.3390\/cells9010111","author":"E Keewan","year":"2020","unstructured":"Keewan E, Naser SA (2020) The role of Notch signaling in macrophages during inflammation and infection: implication in rheumatoid arthritis? Cells. https:\/\/doi.org\/10.3390\/cells9010111","journal-title":"Cells"},{"issue":"2","key":"6566_CR164","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41556-018-0256-3","volume":"21","author":"I Keklikoglou","year":"2019","unstructured":"Keklikoglou I et al (2019) Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models. Nat Cell Biol 21(2):190\u2013202","journal-title":"Nat Cell Biol"},{"issue":"1","key":"6566_CR165","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","volume":"141","author":"K Kessenbrock","year":"2010","unstructured":"Kessenbrock K, Plaks V, Werb Z (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141(1):52\u201367","journal-title":"Cell"},{"issue":"9","key":"6566_CR166","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/s41556-019-0373-7","volume":"21","author":"IS Kim","year":"2019","unstructured":"Kim IS et al (2019) Immuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanisms. Nat Cell Biol 21(9):1113\u20131126","journal-title":"Nat Cell Biol"},{"issue":"2","key":"6566_CR167","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nri3789","volume":"15","author":"T Kitamura","year":"2015","unstructured":"Kitamura T, Qian BZ, Pollard JW (2015) Immune cell promotion of metastasis. Nat Rev Immunol 15(2):73\u201386","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"6566_CR169","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cas.12314","volume":"105","author":"Y Komohara","year":"2014","unstructured":"Komohara Y, Jinushi M, Takeya M (2014) Clinical significance of macrophage heterogeneity in human malignant tumors. Cancer Sci 105(1):1\u20138","journal-title":"Cancer Sci"},{"issue":"19","key":"6566_CR170","doi-asserted-by":"publisher","first-page":"6125","DOI":"10.1158\/1078-0432.CCR-10-2743","volume":"17","author":"H Korkaya","year":"2011","unstructured":"Korkaya H, Liu S, Wicha MS (2011) Regulation of cancer stem cells by cytokine networks: attacking cancer\u2019s inflammatory roots. Clin Cancer Res 17(19):6125\u20136129","journal-title":"Clin Cancer Res"},{"issue":"3","key":"6566_CR171","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.stem.2014.02.006","volume":"14","author":"A Kreso","year":"2014","unstructured":"Kreso A, Dick JE (2014) Evolution of the cancer stem cell model. Cell Stem Cell 14(3):275\u2013291","journal-title":"Cell Stem Cell"},{"issue":"4","key":"6566_CR173","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1084\/jem.20050930","volume":"203","author":"I Kryczek","year":"2006","unstructured":"Kryczek I et al (2006) B7\u2013H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J Exp Med 203(4):871\u2013881","journal-title":"J Exp Med"},{"issue":"6","key":"6566_CR174","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1084\/jem.20082173","volume":"206","author":"DM Kuang","year":"2009","unstructured":"Kuang DM et al (2009) Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1. J Exp Med 206(6):1327\u20131337","journal-title":"J Exp Med"},{"issue":"2","key":"6566_CR175","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.immuni.2016.01.014","volume":"44","author":"V Kumar","year":"2016","unstructured":"Kumar V et al (2016) CD45 phosphatase inhibits STAT3 transcription factor activity in myeloid cells and promotes tumor-associated macrophage differentiation. Immunity 44(2):303\u2013315","journal-title":"Immunity"},{"issue":"7","key":"6566_CR176","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1158\/1535-7163.MCT-17-0998","volume":"17","author":"AT Kurdi","year":"2018","unstructured":"Kurdi AT et al (2018) Antibody-dependent cellular phagocytosis by macrophages is a novel mechanism of action of elotuzumab. Mol Cancer Ther 17(7):1454\u20131463","journal-title":"Mol Cancer Ther"},{"issue":"Pt 2","key":"6566_CR177","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.semcancer.2021.05.022","volume":"86","author":"S Laba","year":"2022","unstructured":"Laba S, Mallett G, Amarnath S (2022) The depths of PD-1 function within the tumor microenvironment beyond CD8(+) T cells. Semin Cancer Biol 86(Pt 2):1045\u20131055","journal-title":"Semin Cancer Biol"},{"key":"6566_CR178","doi-asserted-by":"publisher","first-page":"940","DOI":"10.3389\/fimmu.2020.00940","volume":"11","author":"A Labani-Motlagh","year":"2020","unstructured":"Labani-Motlagh A, Ashja-Mahdavi M, Loskog A (2020) The tumor microenvironment: a milieu hindering and obstructing antitumor immune responses. Front Immunol 11:940","journal-title":"Front Immunol"},{"issue":"5","key":"6566_CR179","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/nm.2129","volume":"16","author":"B Lamprecht","year":"2010","unstructured":"Lamprecht B et al (2010) Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma. Nat Med 16(5):571\u2013579","journal-title":"Nat Med"},{"issue":"26","key":"6566_CR180","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.201701093","volume":"27","author":"T Lang","year":"2017","unstructured":"Lang T et al (2017) Ly6Chi monocytes delivering pH\u2010sensitive micelle loading paclitaxel improve targeting therapy of metastatic breast cancer. Adv Funct Mater 27(26):1701093","journal-title":"Adv Funct Mater"},{"issue":"1","key":"6566_CR181","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-27796-y","volume":"15","author":"Z Lao","year":"2025","unstructured":"Lao Z et al (2025) Single-cell identification of an endothelial cell proximal SPP1(+) macrophage population defines the metastatic vascular niche in lymph nodes. Sci Rep 15(1):43896","journal-title":"Sci Rep"},{"key":"6566_CR182","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/951390","author":"M Lech","year":"2012","unstructured":"Lech M et al (2012) Tissues use resident dendritic cells and macrophages to maintain homeostasis and to regain homeostasis upon tissue injury: the immunoregulatory role of changing tissue environments. Mediators Inflamm. https:\/\/doi.org\/10.1155\/2012\/951390","journal-title":"Mediators Inflamm"},{"issue":"9","key":"6566_CR183","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41577-019-0167-y","volume":"19","author":"G Lemke","year":"2019","unstructured":"Lemke G (2019) How macrophages deal with death. Nat Rev Immunol 19(9):539\u2013549","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"6566_CR185","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1158\/0008-5472.CAN-05-4005","volume":"66","author":"CE Lewis","year":"2006","unstructured":"Lewis CE, Pollard JW (2006) Distinct role of macrophages in different tumor microenvironments. Cancer Res 66(2):605\u2013612","journal-title":"Cancer Res"},{"key":"6566_CR186","doi-asserted-by":"publisher","first-page":"4107","DOI":"10.2147\/IJN.S110146","volume":"11","author":"S Li","year":"2016","unstructured":"Li S et al (2016) Nanomedicine engulfed by macrophages for targeted tumor therapy. Int J Nanomedicine 11:4107\u20134124","journal-title":"Int J Nanomedicine"},{"issue":"15","key":"6566_CR188","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201807211","volume":"31","author":"CX Li","year":"2019","unstructured":"Li CX et al (2019b) Artificially reprogrammed macrophages as tumor-tropic immunosuppression-resistant biologics to realize therapeutics production and immune activation. Adv Mater 31(15):e1807211","journal-title":"Adv Mater"},{"issue":"1","key":"6566_CR187","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12943-019-1102-3","volume":"18","author":"X Li","year":"2019","unstructured":"Li X et al (2019a) Harnessing tumor-associated macrophages as aids for cancer immunotherapy. Mol Cancer 18(1):177","journal-title":"Mol Cancer"},{"key":"6566_CR189","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001341","author":"C Li","year":"2021","unstructured":"Li C et al (2021) Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2020-001341","journal-title":"J Immunother Cancer"},{"issue":"27","key":"6566_CR190","doi-asserted-by":"publisher","first-page":"41662","DOI":"10.18632\/oncotarget.9340","volume":"7","author":"M Liguori","year":"2016","unstructured":"Liguori M et al (2016) Functional TRAIL receptors in monocytes and tumor-associated macrophages: a possible targeting pathway in the tumor microenvironment. Oncotarget 7(27):41662\u201341676","journal-title":"Oncotarget"},{"issue":"44","key":"6566_CR191","doi-asserted-by":"publisher","first-page":"5735","DOI":"10.1038\/onc.2016.107","volume":"35","author":"SY Lim","year":"2016","unstructured":"Lim SY et al (2016) Tumor-infiltrating monocytes\/macrophages promote tumor invasion and migration by upregulating S100A8 and S100A9 expression in cancer cells. Oncogene 35(44):5735\u20135745","journal-title":"Oncogene"},{"issue":"6","key":"6566_CR192","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1084\/jem.193.6.727","volume":"193","author":"EY Lin","year":"2001","unstructured":"Lin EY et al (2001) Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 193(6):727\u2013740","journal-title":"J Exp Med"},{"issue":"5877","key":"6566_CR193","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1126\/science.1154370","volume":"320","author":"H Lin","year":"2008","unstructured":"Lin H et al (2008) Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 320(5877):807\u2013811","journal-title":"Science"},{"key":"6566_CR194","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14102065","author":"CW Lin","year":"2022","unstructured":"Lin CW et al (2022) New horizons of macrophage immunomodulation in the healing of diabetic foot ulcers. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics14102065","journal-title":"Pharmaceutics"},{"issue":"11","key":"6566_CR195","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.tcb.2023.03.008","volume":"33","author":"J Liu","year":"2023","unstructured":"Liu J, Cao X (2023) Glucose metabolism of TAMs in tumor chemoresistance and metastasis. Trends Cell Biol 33(11):967\u2013978","journal-title":"Trends Cell Biol"},{"issue":"2","key":"6566_CR196","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ccell.2016.06.021","volume":"30","author":"Y Liu","year":"2016","unstructured":"Liu Y et al (2016) Tumor exosomal RNAs promote lung pre-metastatic niche formation by activating alveolar epithelial TLR3 to recruit neutrophils. Cancer Cell 30(2):243\u2013256","journal-title":"Cancer Cell"},{"issue":"1","key":"6566_CR197","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40364-020-00251-y","volume":"9","author":"Y Liu","year":"2021","unstructured":"Liu Y et al (2021) Metabolic reprogramming in macrophage responses. Biomark Res 9(1):1","journal-title":"Biomark Res"},{"issue":"10","key":"6566_CR198","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1084\/jem.20180534","volume":"215","author":"PL Loyher","year":"2018","unstructured":"Loyher PL et al (2018) Macrophages of distinct origins contribute to tumor development in the lung. J Exp Med 215(10):2536\u20132553","journal-title":"J Exp Med"},{"issue":"42","key":"6566_CR199","doi-asserted-by":"publisher","first-page":"29087","DOI":"10.1074\/jbc.M109.035899","volume":"284","author":"X Lu","year":"2009","unstructured":"Lu X, Kang Y (2009) Chemokine (C-C motif) ligand 2 engages CCR2+ stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone. J Biol Chem 284(42):29087\u201329096","journal-title":"J Biol Chem"},{"issue":"11","key":"6566_CR200","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/ncb3041","volume":"16","author":"H Lu","year":"2014","unstructured":"Lu H et al (2014) A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages. Nat Cell Biol 16(11):1105\u20131117","journal-title":"Nat Cell Biol"},{"issue":"1","key":"6566_CR201","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13045-024-01535-8","volume":"17","author":"Q Lu","year":"2024","unstructured":"Lu Q et al (2024) Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy. J Hematol Oncol 17(1):16","journal-title":"J Hematol Oncol"},{"issue":"8","key":"6566_CR202","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1172\/JCI27648","volume":"116","author":"Y Luo","year":"2006","unstructured":"Luo Y et al (2006) Targeting tumor-associated macrophages as a novel strategy against breast cancer. J Clin Invest 116(8):2132\u20132141","journal-title":"J Clin Invest"},{"issue":"7","key":"6566_CR203","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.it.2022.04.008","volume":"43","author":"RY Ma","year":"2022","unstructured":"Ma RY, Black A, Qian BZ (2022) Macrophage diversity in cancer revisited in the era of single-cell omics. Trends Immunol 43(7):546\u2013563","journal-title":"Trends Immunol"},{"issue":"1","key":"6566_CR204","first-page":"59","volume":"865","author":"A Mantovani","year":"1986","unstructured":"Mantovani A et al (1986) Origin and regulation of tumor-associated macrophages: the role of tumor-derived chemotactic factor. Biochim Biophys Acta 865(1):59\u201367","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"6566_CR205","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.it.2004.09.015","volume":"25","author":"A Mantovani","year":"2004","unstructured":"Mantovani A et al (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25(12):677\u2013686","journal-title":"Trends Immunol"},{"issue":"7203","key":"6566_CR206","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A et al (2008) Cancer-related inflammation. Nature 454(7203):436\u2013444","journal-title":"Nature"},{"issue":"7","key":"6566_CR207","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","volume":"14","author":"A Mantovani","year":"2017","unstructured":"Mantovani A et al (2017) Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol 14(7):399\u2013416","journal-title":"Nat Rev Clin Oncol"},{"issue":"11","key":"6566_CR208","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","volume":"21","author":"A Mantovani","year":"2022","unstructured":"Mantovani A et al (2022) Macrophages as tools and targets in cancer therapy. Nat Rev Drug Discov 21(11):799\u2013820","journal-title":"Nat Rev Drug Discov"},{"key":"6566_CR209","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf4238","author":"E Mass","year":"2016","unstructured":"Mass E et al (2016) Specification of tissue-resident macrophages during organogenesis. Science. https:\/\/doi.org\/10.1126\/science.aaf4238","journal-title":"Science"},{"key":"6566_CR210","doi-asserted-by":"publisher","first-page":"4189516","DOI":"10.34133\/2021\/4189516","volume":"2021","author":"R Mata","year":"2021","unstructured":"Mata R et al (2021) The dynamic inflammatory tissue microenvironment: signality and disease therapy by biomaterials. Research 2021:4189516","journal-title":"Research"},{"issue":"1","key":"6566_CR211","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/imr.12527","volume":"276","author":"HL Matlung","year":"2017","unstructured":"Matlung HL et al (2017) The CD47-SIRP\u03b1 signaling axis as an innate immune checkpoint in cancer. Immunol Rev 276(1):145\u2013164","journal-title":"Immunol Rev"},{"issue":"4","key":"6566_CR212","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.ccr.2011.02.005","volume":"19","author":"R Mazzieri","year":"2011","unstructured":"Mazzieri R et al (2011) Targeting the ANG2\/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells. Cancer Cell 19(4):512\u2013526","journal-title":"Cancer Cell"},{"key":"6566_CR213","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3389\/fendo.2020.00161","volume":"11","author":"GU Meduri","year":"2020","unstructured":"Meduri GU, Chrousos GP (2020) General adaptation in critical illness: glucocorticoid receptor-alpha master regulator of homeostatic corrections. Front Endocrinol 11:161","journal-title":"Front Endocrinol"},{"key":"6566_CR214","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052662","author":"GF Medvedeva","year":"2021","unstructured":"Medvedeva GF et al (2021) How macrophages become transcriptionally dysregulated: a hidden impact of antitumor therapy. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22052662","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6566_CR215","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s43018-020-00148-7","volume":"2","author":"AK Mehta","year":"2021","unstructured":"Mehta AK et al (2021) Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer. Nat Cancer Inst Monogr 2(1):66\u201382","journal-title":"Nat Cancer Inst Monogr"},{"issue":"23","key":"6566_CR216","doi-asserted-by":"publisher","first-page":"34217","DOI":"10.18632\/oncotarget.9079","volume":"7","author":"J Mei","year":"2016","unstructured":"Mei J et al (2016) Prognostic impact of tumor-associated macrophage infiltration in non-small cell lung cancer: a systemic review and meta-analysis. Oncotarget 7(23):34217\u201334228","journal-title":"Oncotarget"},{"key":"6566_CR217","first-page":"560","volume":"3","author":"E Metchnikoff","year":"1883","unstructured":"Metchnikoff E (1883) Untersuchungen \u00fcber die mesodermalen Phagocyten einiger Wirbeltiere. Biol Zentralbl 3:560\u2013565","journal-title":"Biol Zentralbl"},{"key":"6566_CR218","doi-asserted-by":"publisher","DOI":"10.5962\/bhl.title.29861","volume-title":"Immunity in infective diseases","author":"E Metchnikoff","year":"1905","unstructured":"Metchnikoff E (1905) Immunity in infective diseases. University Press"},{"issue":"3","key":"6566_CR219","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1158\/0008-5472.CAN-12-2731","volume":"73","author":"JB Mitchem","year":"2013","unstructured":"Mitchem JB et al (2013) Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses. Cancer Res 73(3):1128\u20131141","journal-title":"Cancer Res"},{"issue":"1","key":"6566_CR220","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1158\/0008-5472.CAN-13-1816","volume":"74","author":"S Mok","year":"2014","unstructured":"Mok S et al (2014) Inhibition of CSF-1 receptor improves the antitumor efficacy of adoptive cell transfer immunotherapy. Cancer Res 74(1):153\u2013161","journal-title":"Cancer Res"},{"key":"6566_CR221","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112260","volume":"194","author":"S Mondal","year":"2020","unstructured":"Mondal S et al (2020) Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: a minireview. Eur J Med Chem 194:112260","journal-title":"Eur J Med Chem"},{"issue":"19","key":"6566_CR222","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1200\/JCO.2009.25.4037","volume":"28","author":"BJ Monk","year":"2010","unstructured":"Monk BJ et al (2010) Trabectedin plus pegylated liposomal Doxorubicin in recurrent ovarian cancer. J Clin Oncol 28(19):3107\u20133114","journal-title":"J Clin Oncol"},{"issue":"1-2","key":"6566_CR223","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2006.10.023","volume":"183","author":"LB Moran","year":"2007","unstructured":"Moran LB, Duke DC, Graeber MB (2007) The microglial gene regulatory network activated by interferon-gamma. J Neuroimmunol 183(1\u20132):1\u20136","journal-title":"J Neuroimmunol"},{"key":"6566_CR224","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.36688","author":"MA Morrissey","year":"2018","unstructured":"Morrissey MA et al (2018) Chimeric antigen receptors that trigger phagocytosis. Elife. https:\/\/doi.org\/10.7554\/eLife.36688","journal-title":"Elife"},{"key":"6566_CR225","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","volume":"7","author":"TR Mosmann","year":"1989","unstructured":"Mosmann TR, Coffman RL (1989) TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145\u2013173","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"6566_CR226","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1189\/jlb.0602325","volume":"73","author":"DM Mosser","year":"2003","unstructured":"Mosser DM (2003) The many faces of macrophage activation. J Leukoc Biol 73(2):209\u2013212","journal-title":"J Leukoc Biol"},{"issue":"12","key":"6566_CR227","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/nri2448","volume":"8","author":"DM Mosser","year":"2008","unstructured":"Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8(12):958\u2013969","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"6566_CR228","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1158\/2326-6066.CIR-15-0170","volume":"4","author":"JM Mota","year":"2016","unstructured":"Mota JM et al (2016) Post-sepsis state induces tumor-associated macrophage accumulation through CXCR4\/CXCL12 and favors tumor progression in mice. Cancer Immunol Res 4(4):312\u2013322","journal-title":"Cancer Immunol Res"},{"issue":"14","key":"6566_CR229","doi-asserted-by":"publisher","first-page":"5728","DOI":"10.1158\/0008-5472.CAN-09-4672","volume":"70","author":"K Movahedi","year":"2010","unstructured":"Movahedi K et al (2010) Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res 70(14):5728\u20135739","journal-title":"Cancer Res"},{"issue":"9","key":"6566_CR230","doi-asserted-by":"publisher","first-page":"e20210108","DOI":"10.1084\/jem.20210108","volume":"218","author":"C Mowat","year":"2021","unstructured":"Mowat C et al (2021) Anti-tumor immunity in mismatch repair-deficient colorectal cancers requires type I IFN\u2013driven CCL5 and CXCL10. J Exp Med 218(9):e20210108","journal-title":"J Exp Med"},{"issue":"9","key":"6566_CR231","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202105696","volume":"9","author":"AK M\u00fcller","year":"2022","unstructured":"M\u00fcller AK et al (2022) Mouse modeling dissecting macrophage-breast cancer communication uncovered roles of PYK2 in macrophage recruitment and breast tumorigenesis. Adv Sci 9(9):e2105696","journal-title":"Adv Sci"},{"issue":"8","key":"6566_CR232","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/nrc2444","volume":"8","author":"C Murdoch","year":"2008","unstructured":"Murdoch C et al (2008) The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer 8(8):618\u2013631","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"6566_CR233","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.1096\/fj.15-271304","volume":"29","author":"S Murthy","year":"2015","unstructured":"Murthy S et al (2015) Alternative activation of macrophages and pulmonary fibrosis are modulated by scavenger receptor, macrophage receptor with collagenous structure. FASEB J 29(8):3527\u20133536","journal-title":"FASEB J"},{"key":"6566_CR234","doi-asserted-by":"publisher","first-page":"8009","DOI":"10.1038\/ncomms9009","volume":"6","author":"M Muthana","year":"2015","unstructured":"Muthana M et al (2015) Directing cell therapy to anatomic target sites in vivo with magnetic resonance targeting. Nat Commun 6:8009","journal-title":"Nat Commun"},{"issue":"3","key":"6566_CR235","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1161\/CIRCRESAHA.116.309194","volume":"119","author":"M Nahrendorf","year":"2016","unstructured":"Nahrendorf M, Swirski FK (2016) Abandoning M1\/M2 for a network model of macrophage function. Circ Res 119(3):414\u2013417","journal-title":"Circ Res"},{"issue":"1","key":"6566_CR236","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000530","volume":"8","author":"A Naing","year":"2020","unstructured":"Naing A et al (2020) A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti\u2013PD-1 antibody, in patients with advanced solid tumors. J Immunother Cancer 8(1):e000530","journal-title":"J Immunother Cancer"},{"key":"6566_CR237","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan3311","author":"NJ Neubert","year":"2018","unstructured":"Neubert NJ et al (2018) T cell-induced CSF1 promotes melanoma resistance to PD1 blockade. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aan3311","journal-title":"Sci Transl Med"},{"issue":"6","key":"6566_CR238","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1021\/acs.molpharmaceut.5b00987","volume":"13","author":"M Niu","year":"2016","unstructured":"Niu M et al (2016) Tumor-associated macrophage-mediated targeted therapy of triple-negative breast cancer. Mol Pharm 13(6):1833\u20131842","journal-title":"Mol Pharm"},{"issue":"1","key":"6566_CR239","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1128\/iai.8.1.68-73.1973","volume":"8","author":"RJ North","year":"1973","unstructured":"North RJ, Mackaness GB (1973) Immunological control of macrophage proliferation in vivo. Infect Immun 8(1):68\u201373","journal-title":"Infect Immun"},{"issue":"1","key":"6566_CR240","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","volume":"41","author":"R Noy","year":"2014","unstructured":"Noy R, Pollard JW (2014) Tumor-associated macrophages: from mechanisms to therapy. Immunity 41(1):49\u201361","journal-title":"Immunity"},{"issue":"5","key":"6566_CR241","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S1470-2045(16)00078-4","volume":"17","author":"TM Nywening","year":"2016","unstructured":"Nywening TM et al (2016) Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial. Lancet Oncol 17(5):651\u2013662","journal-title":"Lancet Oncol"},{"issue":"7","key":"6566_CR242","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021874","volume":"6","author":"CM Ohri","year":"2011","unstructured":"Ohri CM et al (2011) The tissue microlocalisation and cellular expression of CD163, VEGF, HLA-DR, iNOS, and MRP 8\/14 is correlated to clinical outcome in NSCLC. PLoS ONE 6(7):e21874","journal-title":"PLoS ONE"},{"key":"6566_CR243","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.582939","volume":"11","author":"F Ordikhani","year":"2020","unstructured":"Ordikhani F et al (2020) Macrophages in organ transplantation. Front Immunol 11:582939","journal-title":"Front Immunol"},{"issue":"8","key":"6566_CR244","doi-asserted-by":"publisher","first-page":"4499","DOI":"10.4049\/jimmunol.0802740","volume":"182","author":"S Ostrand-Rosenberg","year":"2009","unstructured":"Ostrand-Rosenberg S, Sinha P (2009) Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol 182(8):4499\u20134506","journal-title":"J Immunol"},{"key":"6566_CR245","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.00602","volume":"11","author":"JG Padron","year":"2020","unstructured":"Padron JG, Saito Reis CA, Kendal-Wright CE (2020) The role of danger associated molecular patterns in human fetal membrane weakening. Front Physiol 11:602","journal-title":"Front Physiol"},{"issue":"5","key":"6566_CR246","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.ccell.2017.10.003","volume":"32","author":"A Palazon","year":"2017","unstructured":"Palazon A et al (2017) An HIF-1\u03b1\/VEGF-A axis in cytotoxic T cells regulates tumor progression. Cancer Cell 32(5):669-683.e5","journal-title":"Cancer Cell"},{"issue":"1","key":"6566_CR247","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41467-020-14433-7","volume":"11","author":"EM Palmieri","year":"2020","unstructured":"Palmieri EM et al (2020) Nitric oxide orchestrates metabolic rewiring in M1 macrophages by targeting aconitase 2 and pyruvate dehydrogenase. Nat Commun 11(1):698","journal-title":"Nat Commun"},{"key":"6566_CR248","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.583084","volume":"11","author":"Y Pan","year":"2020","unstructured":"Pan Y et al (2020) Tumor-associated macrophages in tumor immunity. Front Immunol 11:583084","journal-title":"Front Immunol"},{"issue":"1","key":"6566_CR249","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1080\/10717544.2018.1502839","volume":"25","author":"L Pang","year":"2018","unstructured":"Pang L et al (2018) Primary M1 macrophages as multifunctional carrier combined with PLGA nanoparticle delivering anticancer drug for efficient glioma therapy. Drug Deliv 25(1):1922\u20131931","journal-title":"Drug Deliv"},{"issue":"9","key":"6566_CR250","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1016\/j.celrep.2015.02.024","volume":"10","author":"J Park","year":"2015","unstructured":"Park J et al (2015) M-CSF from cancer cells induces fatty acid synthase and PPAR\u03b2\/\u03b4 activation in tumor myeloid cells, leading to tumor progression. Cell Rep 10(9):1614\u20131625","journal-title":"Cell Rep"},{"issue":"4","key":"6566_CR251","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.it.2019.02.003","volume":"40","author":"P Pathria","year":"2019","unstructured":"Pathria P, Louis TL, Varner JA (2019) Targeting tumor-associated macrophages in cancer. Trends Immunol 40(4):310\u2013327","journal-title":"Trends Immunol"},{"issue":"14","key":"6566_CR252","doi-asserted-by":"publisher","first-page":"7594","DOI":"10.3390\/ijms22147594","volume":"22","author":"R Paudel","year":"2021","unstructured":"Paudel R, Fusi L, Schmidt M (2021) The MEK5\/ERK5 pathway in health and disease. Int J Mol Sci 22(14):7594","journal-title":"Int J Mol Sci"},{"issue":"7","key":"6566_CR254","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.3390\/antiox11071394","volume":"11","author":"S P\u00e9rez","year":"2022","unstructured":"P\u00e9rez S, Rius-P\u00e9rez S (2022) Macrophage polarization and reprogramming in acute inflammation: a redox perspective. Antioxidants 11(7):1394","journal-title":"Antioxidants"},{"issue":"8","key":"6566_CR253","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1191731","volume":"5","author":"HL Penny","year":"2016","unstructured":"Penny HL et al (2016) Warburg metabolism in tumor-conditioned macrophages promotes metastasis in human pancreatic ductal adenocarcinoma. Oncoimmunology 5(8):e1191731","journal-title":"Oncoimmunology"},{"issue":"3","key":"6566_CR255","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2217\/imt-2016-0135","volume":"9","author":"AJ Petty","year":"2017","unstructured":"Petty AJ, Yang Y (2017) Tumor-associated macrophages: implications in cancer immunotherapy. Immunotherapy 9(3):289\u2013302","journal-title":"Immunotherapy"},{"key":"6566_CR256","doi-asserted-by":"publisher","DOI":"10.3390\/cells8121526","author":"AJ Petty","year":"2019","unstructured":"Petty AJ, Yang Y (2019) Tumor-associated macrophages in hematologic malignancies: new insights and targeted therapies. Cells. https:\/\/doi.org\/10.3390\/cells8121526","journal-title":"Cells"},{"issue":"6","key":"6566_CR257","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41571-022-00620-6","volume":"19","author":"MJ Pittet","year":"2022","unstructured":"Pittet MJ, Michielin O, Migliorini D (2022) Clinical relevance of tumour-associated macrophages. Nat Rev Clin Oncol 19(6):402\u2013421","journal-title":"Nat Rev Clin Oncol"},{"key":"6566_CR258","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13122860","author":"AR Poh","year":"2021","unstructured":"Poh AR, Ernst M (2021) Tumor-associated macrophages in pancreatic ductal adenocarcinoma: therapeutic opportunities and clinical challenges. Cancers. https:\/\/doi.org\/10.3390\/cancers13122860","journal-title":"Cancers"},{"key":"6566_CR259","doi-asserted-by":"publisher","DOI":"10.3390\/cells9061535","author":"AS Poltavets","year":"2020","unstructured":"Poltavets AS et al (2020) Macrophage modification strategies for efficient cell therapy. Cells. https:\/\/doi.org\/10.3390\/cells9061535","journal-title":"Cells"},{"issue":"4031","key":"6566_CR260","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1126\/science.176.4031.170","volume":"176","author":"RT Prehn","year":"1972","unstructured":"Prehn RT (1972) The immune reaction as a stimulator of tumor growth. Science 176(4031):170\u2013171","journal-title":"Science"},{"issue":"2","key":"6566_CR261","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/0002-9378(93)90485-2","volume":"168","author":"FV Price","year":"1993","unstructured":"Price FV et al (1993) Colony-stimulating factor-1 in primary ascites of ovarian cancer is a significant predictor of survival. Am J Obstet Gynecol 168(2):520\u2013527","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"6566_CR262","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/nm.3337","volume":"19","author":"SM Pyonteck","year":"2013","unstructured":"Pyonteck SM et al (2013) CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat Med 19(10):1264\u20131272","journal-title":"Nat Med"},{"issue":"8","key":"6566_CR263","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006562","volume":"4","author":"B Qian","year":"2009","unstructured":"Qian B et al (2009) A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth. PLoS ONE 4(8):e6562","journal-title":"PLoS ONE"},{"issue":"7355","key":"6566_CR264","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature10138","volume":"475","author":"BZ Qian","year":"2011","unstructured":"Qian BZ et al (2011) CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475(7355):222\u2013225","journal-title":"Nature"},{"issue":"1","key":"6566_CR265","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12951-019-0513-z","volume":"17","author":"L Qiang","year":"2019","unstructured":"Qiang L et al (2019) A novel macrophage-mediated biomimetic delivery system with NIR-triggered release for prostate cancer therapy. J Nanobiotechnol 17(1):83","journal-title":"J Nanobiotechnol"},{"issue":"2","key":"6566_CR266","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/leu.2016.214","volume":"31","author":"M Qorraj","year":"2017","unstructured":"Qorraj M et al (2017) The PD-1\/PD-L1 axis contributes to immune metabolic dysfunctions of monocytes in chronic lymphocytic leukemia. Leukemia 31(2):470\u2013478","journal-title":"Leukemia"},{"issue":"11","key":"6566_CR267","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA (2013) Microenvironmental regulation of tumor progression and metastasis. Nat Med 19(11):1423\u20131437","journal-title":"Nat Med"},{"issue":"4","key":"6566_CR268","first-page":"376","volume":"4","author":"JG Quatromoni","year":"2012","unstructured":"Quatromoni JG, Eruslanov E (2012) Tumor-associated macrophages: function, phenotype, and link to prognosis in human lung cancer. Am J Transl Res 4(4):376\u2013389","journal-title":"Am J Transl Res"},{"issue":"1","key":"6566_CR269","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2010.01.004","volume":"32","author":"F Radtke","year":"2010","unstructured":"Radtke F, Fasnacht N, Macdonald HR (2010) Notch signaling in the immune system. Immunity 32(1):14\u201327","journal-title":"Immunity"},{"issue":"5","key":"6566_CR270","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1073\/pnas.0409415102","volume":"102","author":"CG Radu","year":"2005","unstructured":"Radu CG et al (2005) Differential proton sensitivity of related G protein-coupled receptors T cell death-associated gene 8 and G2A expressed in immune cells. Proc Natl Acad Sci U S A 102(5):1632\u20131637","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"6566_CR271","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1021\/acs.bioconjchem.7b00768","volume":"29","author":"M Ray","year":"2018","unstructured":"Ray M et al (2018) CRISPRed macrophages for cell-based cancer immunotherapy. Bioconjug Chem 29(2):445\u2013450","journal-title":"Bioconjug Chem"},{"issue":"6","key":"6566_CR272","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.stem.2012.08.013","volume":"11","author":"G Ren","year":"2012","unstructured":"Ren G et al (2012) CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNF\u03b1. Cell Stem Cell 11(6):812\u2013824","journal-title":"Cell Stem Cell"},{"key":"6566_CR273","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.642285","volume":"12","author":"TD Ricketts","year":"2021","unstructured":"Ricketts TD et al (2021) Mechanisms of macrophage plasticity in the tumor environment: manipulating activation state to improve outcomes. Front Immunol 12:642285","journal-title":"Front Immunol"},{"issue":"6","key":"6566_CR274","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.ccr.2014.05.016","volume":"25","author":"CH Ries","year":"2014","unstructured":"Ries CH et al (2014) Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy. Cancer Cell 25(6):846\u2013859","journal-title":"Cancer Cell"},{"issue":"20 Pt 2","key":"6566_CR275","doi-asserted-by":"publisher","first-page":"6222s","DOI":"10.1158\/1078-0432.CCR-06-0843","volume":"12","author":"AJ Roelofs","year":"2006","unstructured":"Roelofs AJ et al (2006) Molecular mechanisms of action of bisphosphonates: current status. Clin Cancer Res 12(20 Pt 2):6222s\u20136230s","journal-title":"Clin Cancer Res"},{"key":"6566_CR276","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/1479-5876-9-177","volume":"9","author":"TL Rogers","year":"2011","unstructured":"Rogers TL, Holen I (2011) Tumour macrophages as potential targets of bisphosphonates. J Transl Med 9:177","journal-title":"J Transl Med"},{"key":"6566_CR277","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201601","author":"BM Rogers","year":"2021","unstructured":"Rogers BM et al (2021) VISTA is an activating receptor in human monocytes. J Exp Med. https:\/\/doi.org\/10.1084\/jem.20201601","journal-title":"J Exp Med"},{"issue":"10","key":"6566_CR278","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1073\/pnas.1414156112","volume":"112","author":"JA Ronald","year":"2015","unstructured":"Ronald JA et al (2015) Detecting cancers through tumor-activatable minicircles that lead to a detectable blood biomarker. Proc Natl Acad Sci U S A 112(10):3068\u20133073","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6566_CR279","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/B978-0-12-514550-3.50013-X","volume-title":"Immunobiology of the macrophage","author":"DL Rosenstreich","year":"1976","unstructured":"Rosenstreich DL, Oppenheim JJ (1976) The role of macrophages in the activation of T and B lymphocytes in vitro. Immunobiology of the macrophage. Elsevier, pp 161\u2013199"},{"issue":"5","key":"6566_CR280","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ctrv.2011.09.001","volume":"38","author":"CS Roxburgh","year":"2012","unstructured":"Roxburgh CS, McMillan DC (2012) The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer. Cancer Treat Rev 38(5):451\u2013466","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"6566_CR281","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.ccell.2015.02.015","volume":"27","author":"B Ruffell","year":"2015","unstructured":"Ruffell B, Coussens LM (2015) Macrophages and therapeutic resistance in cancer. Cancer Cell 27(4):462\u2013472","journal-title":"Cancer Cell"},{"issue":"8","key":"6566_CR282","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1073\/pnas.1104303108","volume":"109","author":"B Ruffell","year":"2012","unstructured":"Ruffell B et al (2012) Leukocyte composition of human breast cancer. Proc Natl Acad Sci U S A 109(8):2796\u20132801","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6566_CR283","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10070905","author":"E Ruiz-Baca","year":"2021","unstructured":"Ruiz-Baca E et al (2021) The role of macrophages in the host\u2019s defense against Sporothrix schenckii. Pathogens. https:\/\/doi.org\/10.3390\/pathogens10070905","journal-title":"Pathogens"},{"issue":"1","key":"6566_CR284","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.bone.2011.04.022","volume":"49","author":"RG Russell","year":"2011","unstructured":"Russell RG (2011) Bisphosphonates: the first 40 years. Bone 49(1):2\u201319","journal-title":"Bone"},{"issue":"6","key":"6566_CR285","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201902599","volume":"7","author":"A Saeed","year":"2020","unstructured":"Saeed A et al (2020) Regulation of cGAS-mediated immune responses and immunotherapy. Adv Sci 7(6):1902599","journal-title":"Adv Sci"},{"issue":"1","key":"6566_CR286","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3164\/jcbn.12-60","volume":"52","author":"H Sakai","year":"2013","unstructured":"Sakai H et al (2013) Effects of anticancer agents on cell viability, proliferative activity and cytokine production of peripheral blood mononuclear cells. J Clin Biochem Nutr 52(1):64\u201371","journal-title":"J Clin Biochem Nutr"},{"issue":"1","key":"6566_CR287","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00109-020-01988-7","volume":"99","author":"A Salminen","year":"2021","unstructured":"Salminen A (2021) Increased immunosuppression impairs tissue homeostasis with aging and age-related diseases. J Mol Med 99(1):1\u201320","journal-title":"J Mol Med"},{"issue":"4","key":"6566_CR288","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s00280-013-2099-8","volume":"71","author":"SK Sandhu","year":"2013","unstructured":"Sandhu SK et al (2013) A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors. Cancer Chemother Pharmacol 71(4):1041\u20131050","journal-title":"Cancer Chemother Pharmacol"},{"issue":"13","key":"6566_CR289","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1158\/1078-0432.CCR-13-0525","volume":"19","author":"DE Sanford","year":"2013","unstructured":"Sanford DE et al (2013) Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2\/CCR2 axis. Clin Cancer Res 19(13):3404\u20133415","journal-title":"Clin Cancer Res"},{"issue":"21","key":"6566_CR290","doi-asserted-by":"publisher","first-page":"9050","DOI":"10.1158\/0008-5472.CAN-08-1327","volume":"68","author":"S Sangaletti","year":"2008","unstructured":"Sangaletti S et al (2008) Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasis. Cancer Res 68(21):9050\u20139059","journal-title":"Cancer Res"},{"issue":"1","key":"6566_CR292","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/153537020422900101","volume":"229","author":"E Sapi","year":"2004","unstructured":"Sapi E (2004) The role of CSF-1 in normal physiology of mammary gland and breast cancer: an update. Exp Biol Med 229(1):1\u201311","journal-title":"Exp Biol Med"},{"issue":"19","key":"6566_CR293","doi-asserted-by":"publisher","first-page":"4278","DOI":"10.1158\/1078-0432.CCR-14-0914","volume":"21","author":"S Scala","year":"2015","unstructured":"Scala S (2015) Molecular pathways: targeting the CXCR4-CXCL12 axis-untapped potential in the tumor microenvironment. Clin Cancer Res 21(19):4278\u20134285","journal-title":"Clin Cancer Res"},{"issue":"1","key":"6566_CR294","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1749-6632.1993.tb17199.x","volume":"698","author":"SM Scholl","year":"1993","unstructured":"Scholl SM et al (1993) Expression of colony-stimulating factor-1 and its receptor (the protein product of c-fms) in invasive breast tumor cells: induction of Urokinase production via this pathway? Ann NY Acad Sci 698(1):131\u2013135","journal-title":"Ann NY Acad Sci"},{"issue":"2","key":"6566_CR295","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/bjc.1994.62","volume":"69","author":"SM Scholl","year":"1994","unstructured":"Scholl SM et al (1994) Circulating levels of colony-stimulating factor 1 as a prognostic indicator in 82 patients with epithelial ovarian cancer. Br J Cancer 69(2):342\u2013346","journal-title":"Br J Cancer"},{"issue":"1\u20132","key":"6566_CR296","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cell.2012.12.012","volume":"152","author":"S Schwitalla","year":"2013","unstructured":"Schwitalla S et al (2013) Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties. Cell 152(1\u20132):25\u201338","journal-title":"Cell"},{"issue":"8","key":"6566_CR297","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202104372","volume":"9","author":"HS Schymik","year":"2022","unstructured":"Schymik HS et al (2022) Comment on: the m6A reader IGF2BP2 regulates macrophage phenotypic activation and inflammatory diseases by stabilizing TSC1 and PPAR\u03b3. Adv Sci 9(8):e2104372","journal-title":"Adv Sci"},{"key":"6566_CR298","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.748663","volume":"12","author":"ZA Shaheryar","year":"2021","unstructured":"Shaheryar ZA et al (2021) Neuroinflammatory triangle presenting novel pharmacological targets for ischemic brain injury. Front Immunol 12:748663","journal-title":"Front Immunol"},{"issue":"9","key":"6566_CR299","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.1002\/jcp.26429","volume":"233","author":"A Shapouri-Moghaddam","year":"2018","unstructured":"Shapouri-Moghaddam A et al (2018) Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol 233(9):6425\u20136440","journal-title":"J Cell Physiol"},{"issue":"4","key":"6566_CR300","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","volume":"168","author":"P Sharma","year":"2017","unstructured":"Sharma P et al (2017) Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell 168(4):707\u2013723","journal-title":"Cell"},{"issue":"11","key":"6566_CR301","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.4161\/hv.29275","volume":"10","author":"KY Shen","year":"2014","unstructured":"Shen KY et al (2014) Depletion of tumor-associated macrophages enhances the anti-tumor immunity induced by a Toll-like receptor agonist-conjugated peptide. Hum Vaccin Immunother 10(11):3241\u20133250","journal-title":"Hum Vaccin Immunother"},{"key":"6566_CR302","doi-asserted-by":"publisher","DOI":"10.1038\/srep38362","volume":"6","author":"L Shen","year":"2016","unstructured":"Shen L et al (2016) PD-1\/PD-L pathway inhibits M.tb-specific CD4(+) T-cell functions and phagocytosis of macrophages in active tuberculosis. Sci Rep 6:38362","journal-title":"Sci Rep"},{"issue":"9","key":"6566_CR303","doi-asserted-by":"publisher","first-page":"4722","DOI":"10.4049\/jimmunol.1401160","volume":"193","author":"M Singh","year":"2014","unstructured":"Singh M et al (2014) Effective innate and adaptive antimelanoma immunity through localized TLR7\/8 activation. J Immunol 193(9):4722\u20134731","journal-title":"J Immunol"},{"issue":"3","key":"6566_CR304","first-page":"313","volume":"1","author":"HO Smith","year":"1995","unstructured":"Smith HO et al (1995) The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma. Clin Cancer Res 1(3):313\u2013325","journal-title":"Clin Cancer Res"},{"issue":"1","key":"6566_CR305","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.molonc.2012.07.002","volume":"7","author":"HO Smith","year":"2013","unstructured":"Smith HO et al (2013) The clinical significance of inflammatory cytokines in primary cell culture in endometrial carcinoma. Mol Oncol 7(1):41\u201354","journal-title":"Mol Oncol"},{"issue":"6","key":"6566_CR306","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nnano.2014.62","volume":"9","author":"BR Smith","year":"2014","unstructured":"Smith BR et al (2014) Selective uptake of single-walled carbon nanotubes by circulating monocytes for enhanced tumour delivery. Nat Nanotechnol 9(6):481\u2013487","journal-title":"Nat Nanotechnol"},{"issue":"6","key":"6566_CR307","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1093\/neuonc\/nov272","volume":"18","author":"JH Stafford","year":"2016","unstructured":"Stafford JH et al (2016) Colony stimulating factor 1 receptor inhibition delays recurrence of glioblastoma after radiation by altering myeloid cell recruitment and polarization. Neuro Oncol 18(6):797\u2013806","journal-title":"Neuro Oncol"},{"key":"6566_CR308","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a021857","author":"ER Stanley","year":"2014","unstructured":"Stanley ER, Chitu V (2014) CSF-1 receptor signaling in myeloid cells. Cold Spring Harb Perspect Biol. https:\/\/doi.org\/10.1101\/cshperspect.a021857","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"6","key":"6566_CR309","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.3390\/ijms20061426","volume":"20","author":"B Stecca","year":"2019","unstructured":"Stecca B, Rovida E (2019) Impact of ERK5 on the hallmarks of cancer. Int J Mol Sci 20(6):1426","journal-title":"Int J Mol Sci"},{"issue":"10","key":"6566_CR310","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1056\/NEJMoa0905680","volume":"362","author":"C Steidl","year":"2010","unstructured":"Steidl C et al (2010) Tumor-associated macrophages and survival in classic Hodgkin\u2019s lymphoma. N Engl J Med 362(10):875\u2013885","journal-title":"N Engl J Med"},{"issue":"1","key":"6566_CR311","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1084\/jem.176.1.287","volume":"176","author":"M Stein","year":"1992","unstructured":"Stein M et al (1992) Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 176(1):287\u2013292","journal-title":"J Exp Med"},{"issue":"8","key":"6566_CR312","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.4049\/jimmunol.2000185","volume":"205","author":"KJ Steinberger","year":"2020","unstructured":"Steinberger KJ et al (2020) Hypoxia-inducible factor \u03b1 subunits regulate Tie2-expressing macrophages that influence tumor oxygen and perfusion in murine breast cancer. J Immunol 205(8):2301\u20132311","journal-title":"J Immunol"},{"issue":"12","key":"6566_CR313","doi-asserted-by":"publisher","DOI":"10.4161\/onci.26968","volume":"2","author":"DC Strachan","year":"2013","unstructured":"Strachan DC et al (2013) CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8(+) T cells. Oncoimmunology 2(12):e26968","journal-title":"Oncoimmunology"},{"issue":"43","key":"6566_CR314","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1126\/sciimmunol.aay1863","volume":"5","author":"L Strauss","year":"2020","unstructured":"Strauss L et al (2020) Targeted deletion of PD-1 in myeloid cells induces antitumor immunity. Sci Immunol 5(43):1863","journal-title":"Sci Immunol"},{"issue":"6","key":"6566_CR315","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1158\/2326-6066.CIR-18-0448","volume":"7","author":"IM Stromnes","year":"2019","unstructured":"Stromnes IM et al (2019) Differential effects of depleting versus programming tumor-associated macrophages on engineered T cells in pancreatic ductal adenocarcinoma. Cancer Immunol Res 7(6):977\u2013989","journal-title":"Cancer Immunol Res"},{"issue":"2","key":"6566_CR316","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cell.2018.09.007","volume":"175","author":"S Su","year":"2018","unstructured":"Su S et al (2018) Immune checkpoint inhibition overcomes ADCP-induced immunosuppression by macrophages. Cell 175(2):442-457.e23","journal-title":"Cell"},{"issue":"7","key":"6566_CR317","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1084\/jem.20051848","volume":"203","author":"H Sumimoto","year":"2006","unstructured":"Sumimoto H et al (2006) The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells. J Exp Med 203(7):1651\u20131656","journal-title":"J Exp Med"},{"issue":"10","key":"6566_CR318","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000859","volume":"18","author":"KM Summers","year":"2020","unstructured":"Summers KM, Bush SJ, Hume DA (2020) Network analysis of transcriptomic diversity amongst resident tissue macrophages and dendritic cells in the mouse mononuclear phagocyte system. PLoS Biol 18(10):e3000859","journal-title":"PLoS Biol"},{"key":"6566_CR319","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22157970","author":"M Suuring","year":"2021","unstructured":"Suuring M, Moreau A (2021) Regulatory macrophages and tolerogenic dendritic cells in myeloid regulatory cell-based therapies. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22157970","journal-title":"Int J Mol Sci"},{"issue":"9","key":"6566_CR320","doi-asserted-by":"publisher","first-page":"4679","DOI":"10.3390\/ijms25094679","volume":"25","author":"D Szukiewicz","year":"2024","unstructured":"Szukiewicz D (2024) CX3CL1 (Fractalkine)-CX3CR1 axis in inflammation-induced angiogenesis and tumorigenesis. Int J Mol Sci 25(9):4679","journal-title":"Int J Mol Sci"},{"issue":"4","key":"6566_CR321","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/jcb.240500403","volume":"50","author":"R Tang","year":"1992","unstructured":"Tang R et al (1992) M-CSF (monocyte colony stimulating factor) and M-CSF receptor expression by breast tumour cells: M-CSF mediated recruitment of tumour infiltrating monocytes? J Cell Biochem 50(4):350\u2013356","journal-title":"J Cell Biochem"},{"issue":"2","key":"6566_CR322","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1172\/JCI96061","volume":"128","author":"H Tang","year":"2018","unstructured":"Tang H et al (2018) PD-L1 on host cells is essential for PD-L1 blockade-mediated tumor regression. J Clin Invest 128(2):580\u2013588","journal-title":"J Clin Invest"},{"issue":"2","key":"6566_CR323","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.nano.2012.10.006","volume":"9","author":"Y Tao","year":"2013","unstructured":"Tao Y, Ning M, Dou H (2013) A novel therapeutic system for malignant glioma: nanoformulation, pharmacokinetic, and anticancer properties of cell-nano-drug delivery. Nanomedicine 9(2):222\u2013232","journal-title":"Nanomedicine"},{"issue":"5","key":"6566_CR324","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1056\/NEJMoa1411366","volume":"373","author":"WD Tap","year":"2015","unstructured":"Tap WD et al (2015) Structure-guided blockade of CSF1R kinase in tenosynovial giant-cell tumor. N Engl J Med 373(5):428\u2013437","journal-title":"N Engl J Med"},{"issue":"11","key":"6566_CR325","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1158\/1078-0432.CCR-09-2329","volume":"16","author":"BA Teicher","year":"2010","unstructured":"Teicher BA, Fricker SP (2010) CXCL12 (SDF-1)\/CXCR4 pathway in cancer. Clin Cancer Res 16(11):2927\u20132931","journal-title":"Clin Cancer Res"},{"issue":"24","key":"6566_CR326","doi-asserted-by":"publisher","first-page":"6140","DOI":"10.3390\/ijms20246140","volume":"20","author":"AA Tirpe","year":"2019","unstructured":"Tirpe AA et al (2019) Hypoxia: overview on hypoxia-mediated mechanisms with a focus on the role of HIF genes. Int J Mol Sci 20(24):6140","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6566_CR327","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.canlet.2016.03.036","volume":"376","author":"H Tong","year":"2016","unstructured":"Tong H et al (2016) Tumor-associated macrophage-derived CXCL8 could induce ER\u03b1 suppression via HOXB13 in endometrial cancer. Cancer Lett 376(1):127\u2013136","journal-title":"Cancer Lett"},{"issue":"5","key":"6566_CR328","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrc.2016.36","volume":"16","author":"SL Topalian","year":"2016","unstructured":"Topalian SL et al (2016) Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy. Nat Rev Cancer 16(5):275\u2013287","journal-title":"Nat Rev Cancer"},{"issue":"27","key":"6566_CR329","doi-asserted-by":"publisher","first-page":"11103","DOI":"10.1073\/pnas.1305569110","volume":"110","author":"D Tseng","year":"2013","unstructured":"Tseng D et al (2013) Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response. Proc Natl Acad Sci U S A 110(27):11103\u201311108","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"6566_CR330","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1038\/onc.2014.191","volume":"34","author":"V Ubertini","year":"2015","unstructured":"Ubertini V et al (2015) Mutant p53 gains new function in promoting inflammatory signals by repression of the secreted interleukin-1 receptor antagonist. Oncogene 34(19):2493\u20132504","journal-title":"Oncogene"},{"issue":"6","key":"6566_CR331","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s004280100458","volume":"440","author":"T Valkovi\u0107","year":"2002","unstructured":"Valkovi\u0107 T et al (2002) Correlation between vascular endothelial growth factor, angiogenesis, and tumor-associated macrophages in invasive ductal breast carcinoma. Virchows Arch 440(6):583\u2013588","journal-title":"Virchows Arch"},{"key":"6566_CR332","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.pharmthera.2015.11.008","volume":"158","author":"HH Van Acker","year":"2016","unstructured":"Van Acker HH et al (2016) Bisphosphonates for cancer treatment: mechanisms of action and lessons from clinical trials. Pharmacol Ther 158:24\u201340","journal-title":"Pharmacol Ther"},{"issue":"1-2","key":"6566_CR333","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1081\/LPR-120004780","volume":"12","author":"N van Rooijen","year":"2002","unstructured":"van Rooijen N, van Kesteren-Hendrikx E (2002) Clodronate liposomes: perspectives in research and therapeutics. J Liposome Res 12(1\u20132):81\u201394","journal-title":"J Liposome Res"},{"issue":"10","key":"6566_CR334","doi-asserted-by":"publisher","first-page":"5242","DOI":"10.1158\/0008-5472.CAN-05-4463","volume":"66","author":"O Vasiljeva","year":"2006","unstructured":"Vasiljeva O et al (2006) Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer. Cancer Res 66(10):5242\u20135250","journal-title":"Cancer Res"},{"issue":"5","key":"6566_CR336","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1084\/jem.127.5.943","volume":"127","author":"M Virolainen","year":"1968","unstructured":"Virolainen M (1968) Hematopoietic origin of macrophages as studied by chromosome markers in mice. J Exp Med 127(5):943\u2013952","journal-title":"J Exp Med"},{"issue":"1","key":"6566_CR337","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cmet.2019.06.001","volume":"30","author":"I Vitale","year":"2019","unstructured":"Vitale I et al (2019) Macrophages and metabolism in the tumor microenvironment. Cell Metab 30(1):36\u201350","journal-title":"Cell Metab"},{"issue":"5","key":"6566_CR338","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00262-013-1427-5","volume":"62","author":"RH Vonderheide","year":"2013","unstructured":"Vonderheide RH et al (2013) CD40 immunotherapy for pancreatic cancer. Cancer Immunol Immunother 62(5):949\u2013954","journal-title":"Cancer Immunol Immunother"},{"issue":"6","key":"6566_CR339","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1053\/j.gastro.2014.08.039","volume":"147","author":"S Wan","year":"2014","unstructured":"Wan S et al (2014) Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells. Gastroenterology 147(6):1393\u20131404","journal-title":"Gastroenterology"},{"issue":"12","key":"6566_CR340","doi-asserted-by":"publisher","first-page":"4840","DOI":"10.1158\/0008-5472.CAN-10-0269","volume":"70","author":"YC Wang","year":"2010","unstructured":"Wang YC et al (2010) Notch signaling determines the M1 versus M2 polarization of macrophages in antitumor immune responses. Cancer Res 70(12):4840\u20134849","journal-title":"Cancer Res"},{"issue":"3","key":"6566_CR341","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1084\/jem.20100619","volume":"208","author":"L Wang","year":"2011","unstructured":"Wang L et al (2011) VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses. J Exp Med 208(3):577\u2013592","journal-title":"J Exp Med"},{"issue":"8","key":"6566_CR342","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/ni.2360","volume":"13","author":"Y Wang","year":"2012","unstructured":"Wang Y et al (2012) IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nat Immunol 13(8):753\u2013760","journal-title":"Nat Immunol"},{"key":"6566_CR343","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3389\/fimmu.2014.00614","volume":"5","author":"N Wang","year":"2014","unstructured":"Wang N, Liang H, Zen K (2014) Molecular mechanisms that influence the macrophage M1\u2013M2 polarization balance. Front Immunol 5:614","journal-title":"Front Immunol"},{"issue":"2","key":"6566_CR345","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2217\/nnm-2017-0266","volume":"13","author":"C Wang","year":"2018","unstructured":"Wang C et al (2018b) Monocyte-mediated chemotherapy drug delivery in glioblastoma. Nanomedicine 13(2):157\u2013178","journal-title":"Nanomedicine"},{"issue":"3","key":"6566_CR344","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.cmet.2018.08.012","volume":"28","author":"F Wang","year":"2018","unstructured":"Wang F et al (2018a) Glycolytic stimulation is not a requirement for M2 macrophage differentiation. Cell Metab 28(3):463-475.e4","journal-title":"Cell Metab"},{"issue":"13","key":"6566_CR346","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202100209","volume":"8","author":"X Wang","year":"2021","unstructured":"Wang X et al (2021) The m6A reader IGF2BP2 regulates macrophage phenotypic activation and inflammatory diseases by stabilizing TSC1 and PPAR\u03b3. Adv Sci 8(13):2100209","journal-title":"Adv Sci"},{"issue":"9","key":"6566_CR347","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1084\/jem.20160392","volume":"214","author":"B Weichand","year":"2017","unstructured":"Weichand B et al (2017) S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3\/IL-1\u03b2. J Exp Med 214(9):2695\u20132713","journal-title":"J Exp Med"},{"key":"6566_CR348","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ejca.2017.02.013","volume":"76","author":"K Weiskopf","year":"2017","unstructured":"Weiskopf K (2017) Cancer immunotherapy targeting the CD47\/SIRP\u03b1 axis. Eur J Cancer 76:100\u2013109","journal-title":"Eur J Cancer"},{"issue":"6141","key":"6566_CR349","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1126\/science.1238856","volume":"341","author":"K Weiskopf","year":"2013","unstructured":"Weiskopf K et al (2013) Engineered SIRP\u03b1 variants as immunotherapeutic adjuvants to anticancer antibodies. Science 341(6141):88\u201391","journal-title":"Science"},{"issue":"6","key":"6566_CR350","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0030187","volume":"3","author":"RB West","year":"2005","unstructured":"West RB et al (2005) Determination of stromal signatures in breast carcinoma. PLoS Biol 3(6):e187","journal-title":"PLoS Biol"},{"key":"6566_CR351","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.830350","volume":"12","author":"AJ West","year":"2022","unstructured":"West AJ et al (2022) Inflammasome-associated gastric tumorigenesis is independent of the NLRP3 pattern recognition receptor. Front Oncol 12:830350","journal-title":"Front Oncol"},{"issue":"12","key":"6566_CR352","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1158\/2326-6066.CIR-17-0258","volume":"5","author":"KR Wiehagen","year":"2017","unstructured":"Wiehagen KR et al (2017) Combination of CD40 agonism and CSF-1R blockade reconditions tumor-associated macrophages and drives potent antitumor immunity. Cancer Immunol Res 5(12):1109\u20131121","journal-title":"Cancer Immunol Res"},{"issue":"17","key":"6566_CR353","doi-asserted-by":"publisher","first-page":"6662","DOI":"10.1073\/pnas.1121623109","volume":"109","author":"SB Willingham","year":"2012","unstructured":"Willingham SB et al (2012) The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proc Natl Acad Sci USA 109(17):6662\u20136667","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"6566_CR354","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","volume":"53","author":"SZ Wu","year":"2021","unstructured":"Wu SZ et al (2021) A single-cell and spatially resolved atlas of human breast cancers. Nat Genet 53(9):1334\u20131347","journal-title":"Nat Genet"},{"issue":"40","key":"6566_CR355","doi-asserted-by":"publisher","first-page":"eado8366","DOI":"10.1126\/sciadv.ado8366","volume":"10","author":"N Wu","year":"2024","unstructured":"Wu N et al (2024) MerTK(+) macrophages promote melanoma progression and immunotherapy resistance through AhR-ALKAL1 activation. Sci Adv 10(40):eado8366","journal-title":"Sci Adv"},{"issue":"7446","key":"6566_CR356","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nature12034","volume":"496","author":"TA Wynn","year":"2013","unstructured":"Wynn TA, Chawla A, Pollard JW (2013) Macrophage biology in development, homeostasis and disease. Nature 496(7446):445\u2013455","journal-title":"Nature"},{"issue":"40","key":"6566_CR357","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202002054","volume":"32","author":"Y Xia","year":"2020","unstructured":"Xia Y et al (2020) Engineering macrophages for cancer immunotherapy and drug delivery. Adv Mater 32(40):e2002054","journal-title":"Adv Mater"},{"issue":"13","key":"6566_CR358","doi-asserted-by":"publisher","first-page":"5341","DOI":"10.1007\/s00253-021-11406-8","volume":"105","author":"P Xia","year":"2021","unstructured":"Xia P et al (2021) Research progress on Toll-like receptor signal transduction and its roles in antimicrobial immune responses. Appl Microbiol Biotechnol 105(13):5341\u20135355","journal-title":"Appl Microbiol Biotechnol"},{"issue":"11","key":"6566_CR359","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1158\/2326-6066.CIR-23-0627","volume":"12","author":"X Xiang","year":"2024","unstructured":"Xiang X et al (2024) Blocking CX3CR1+ tumor-associated macrophages enhances the efficacy of anti-PD1 therapy in hepatocellular carcinoma. Cancer Immunol Res 12(11):1603\u20131620","journal-title":"Cancer Immunol Res"},{"key":"6566_CR360","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-013145","author":"X Xiang","year":"2025","unstructured":"Xiang X et al (2025) CLEVER-1 blockade reprograms TAMs to overcome anti-PD-1 resistance in gastric cancer. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2025-013145","journal-title":"J Immunother Cancer"},{"issue":"1","key":"6566_CR361","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41392-025-02325-5","volume":"10","author":"J Xu","year":"2025","unstructured":"Xu J et al (2025) Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments. Signal Transduct Target Ther 10(1):268","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"6566_CR362","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/stem.1281","volume":"31","author":"J Yang","year":"2013","unstructured":"Yang J et al (2013) Tumor-associated macrophages regulate murine breast cancer stem cells through a novel paracrine EGFR\/Stat3\/Sox-2 signaling pathway. Stem Cells 31(2):248\u2013258","journal-title":"Stem Cells"},{"issue":"28","key":"6566_CR363","doi-asserted-by":"publisher","first-page":"44478","DOI":"10.18632\/oncotarget.9873","volume":"7","author":"Z Yang","year":"2016","unstructured":"Yang Z et al (2016) Infiltrating macrophages increase RCC epithelial mesenchymal transition (EMT) and stem cell-like populations via AKT and mTOR signaling. Oncotarget 7(28):44478\u201344491","journal-title":"Oncotarget"},{"issue":"11","key":"6566_CR364","first-page":"4096","volume":"6","author":"J Ye","year":"2021","unstructured":"Ye J et al (2021) Promoting musculoskeletal system soft tissue regeneration by biomaterial-mediated modulation of macrophage polarization. Bioact Mater 6(11):4096\u20134109","journal-title":"Bioact Mater"},{"issue":"11","key":"6566_CR365","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1158\/0008-5472.CAN-13-2421","volume":"74","author":"EJ Yeo","year":"2014","unstructured":"Yeo EJ et al (2014) Myeloid WNT7b mediates the angiogenic switch and metastasis in breast cancer. Cancer Res 74(11):2962\u20132973","journal-title":"Cancer Res"},{"issue":"1","key":"6566_CR366","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170042","volume":"12","author":"S Yin","year":"2017","unstructured":"Yin S et al (2017) The prognostic and clinicopathological significance of tumor-associated macrophages in patients with gastric cancer: a meta-analysis. PLoS ONE 12(1):e0170042","journal-title":"PLoS ONE"},{"issue":"9","key":"6566_CR367","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202102620","volume":"9","author":"Y Yin","year":"2022","unstructured":"Yin Y et al (2022) Colorectal cancer-derived small extracellular vesicles promote tumor immune evasion by upregulating PD-L1 expression in tumor-associated macrophages. Adv Sci 9(9):2102620","journal-title":"Adv Sci"},{"issue":"1","key":"6566_CR368","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.immuni.2012.12.001","volume":"38","author":"S Yona","year":"2013","unstructured":"Yona S et al (2013) Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 38(1):79\u201391","journal-title":"Immunity"},{"issue":"1","key":"6566_CR369","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41591-020-1131-x","volume":"27","author":"J Yu","year":"2021","unstructured":"Yu J et al (2021) Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination. Nat Med 27(1):152\u2013164","journal-title":"Nat Med"},{"key":"6566_CR370","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-011080","author":"K Yu","year":"2025","unstructured":"Yu K et al (2025) Blockade of CLEVER-1 restrains immune evasion and enhances anti-PD-1 immunotherapy in gastric cancer. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2024-011080","journal-title":"J Immunother Cancer"},{"issue":"12","key":"6566_CR371","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050946","volume":"7","author":"QW Zhang","year":"2012","unstructured":"Zhang QW et al (2012) Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature. PLoS ONE 7(12):e50946","journal-title":"PLoS ONE"},{"issue":"4","key":"6566_CR372","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1007\/s10120-014-0422-7","volume":"18","author":"H Zhang","year":"2015","unstructured":"Zhang H et al (2015) Infiltration of diametrically polarized macrophages predicts overall survival of patients with gastric cancer after surgical resection. Gastric Cancer 18(4):740\u2013750","journal-title":"Gastric Cancer"},{"issue":"59","key":"6566_CR373","doi-asserted-by":"publisher","first-page":"99801","DOI":"10.18632\/oncotarget.21068","volume":"8","author":"S Zhang","year":"2017","unstructured":"Zhang S et al (2017) Tumor-associated macrophages promote tumor metastasis via the TGF-\u03b2\/SOX9 axis in non-small cell lung cancer. Oncotarget 8(59):99801\u201399815","journal-title":"Oncotarget"},{"key":"6566_CR374","doi-asserted-by":"publisher","DOI":"10.3390\/cells10040903","author":"XM Zhang","year":"2021","unstructured":"Zhang XM et al (2021) Embryonic origin and subclonal evolution of tumor-associated macrophages imply preventive care for cancer. Cells. https:\/\/doi.org\/10.3390\/cells10040903","journal-title":"Cells"},{"issue":"1","key":"6566_CR375","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13062-023-00401-w","volume":"18","author":"Y Zhang","year":"2023","unstructured":"Zhang Y et al (2023) ILC1-derived IFN-\u03b3 regulates macrophage activation in colon cancer. Biol Direct 18(1):56","journal-title":"Biol Direct"},{"issue":"5","key":"6566_CR376","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.2001","volume":"16","author":"JY Zhang","year":"2024","unstructured":"Zhang JY et al (2024) Recent progress on nanomedicine-mediated repolarization of tumor-associated macrophages for cancer immunotherapy. Wires Nanomed Nanobiotechnol 16(5):e2001","journal-title":"Wires Nanomed Nanobiotechnol"},{"issue":"1","key":"6566_CR377","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12943-025-02305-x","volume":"24","author":"M Zhang","year":"2025","unstructured":"Zhang M et al (2025) Advances in cancer immunotherapy: historical perspectives, current developments, and future directions. Mol Cancer 24(1):136","journal-title":"Mol Cancer"},{"issue":"18","key":"6566_CR378","doi-asserted-by":"publisher","first-page":"30576","DOI":"10.18632\/oncotarget.15736","volume":"8","author":"X Zhao","year":"2017","unstructured":"Zhao X et al (2017) Prognostic significance of tumor-associated macrophages in breast cancer: a meta-analysis of the literature. Oncotarget 8(18):30576\u201330586","journal-title":"Oncotarget"},{"issue":"1","key":"6566_CR379","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","volume":"6","author":"H Zhao","year":"2021","unstructured":"Zhao H et al (2021) Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduct Target Ther 6(1):263","journal-title":"Signal Transduct Target Ther"},{"key":"6566_CR380","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1526668","volume":"16","author":"T Zhao","year":"2025","unstructured":"Zhao T et al (2025) Characterizing macrophage diversity in colorectal malignancies through single-cell genomics. Front Immunol 16:1526668","journal-title":"Front Immunol"},{"issue":"11","key":"6566_CR381","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.3390\/pharmaceutics14112285","volume":"14","author":"R Zheng","year":"2022","unstructured":"Zheng R, Ma J (2022) Immunotherapeutic implications of toll-like receptors activation in tumor microenvironment. Pharmaceutics 14(11):2285","journal-title":"Pharmaceutics"},{"issue":"1","key":"6566_CR382","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1021\/jacs.9b11046","volume":"142","author":"L Zheng","year":"2020","unstructured":"Zheng L et al (2020) In vivo monocyte\/macrophage-hitchhiked intratumoral accumulation of nanomedicines for enhanced tumor therapy. J Am Chem Soc 142(1):382\u2013391","journal-title":"J Am Chem Soc"},{"issue":"18","key":"6566_CR383","doi-asserted-by":"publisher","first-page":"5057","DOI":"10.1158\/0008-5472.CAN-13-3723","volume":"74","author":"Y Zhu","year":"2014","unstructured":"Zhu Y et al (2014) CSF1\/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models. Cancer Res 74(18):5057\u20135069","journal-title":"Cancer Res"},{"issue":"2","key":"6566_CR384","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.immuni.2017.07.014","volume":"47","author":"Y Zhu","year":"2017","unstructured":"Zhu Y et al (2017) Tissue-resident macrophages in pancreatic ductal adenocarcinoma originate from embryonic hematopoiesis and promote tumor progression. Immunity 47(2):323-338.e6","journal-title":"Immunity"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-026-06566-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-026-06566-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-026-06566-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:02:23Z","timestamp":1792684943000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-026-06566-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":379,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["6566"],"URL":"https:\/\/doi.org\/10.1007\/s00432-026-06566-x","relation":{},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"14 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"200"}}